EurekaMag PDF full texts Chapter 31,697

Standley, S.; Tocco, G.; Wagle, N.; Baudry, M. 1998: High- and low-affinity alpha- amino-3-hydroxy-5-methylisoxazole-4-propionic acid binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits. Journal of Neurochemistry 70(6): 2434-2445

Momiyama, A. 1998: High- and low-conductance NMDA receptors in adult rat spinal cord neurons. Neuroscience Research Suppl (22): S85

Aydin-Abidin, S.; Trippe, J.ör.; Funke, K.; Eysel, U.T.; Benali, A. 2008: High- and low-frequency repetitive transcranial magnetic stimulation differentially activates c-Fos and zif268 protein expression in the rat brain. Experimental Brain Research 188(2): 249-261

D.L.Chapelle, Albert 1998: High- and low-penetrance genes in cancer predispositions. European Journal of Human Genetics 6(Suppl 1): 29

Zeng, Y.; Wu, Y.; Avigne, W.T.; Koch, K.E. 1997: High- and low-sugar-inducible genes for sucrose synthase are respectively upregulated by distinct hypoxic and anoxic signals. Plant Physiology (Rockville) 114(3 Suppl): 79

Stefanov, D.; Tsonev, T.; Velinov, T.; Gateshki, M.; Branzalov, K.; Yordanov, I. 1998: High- and low-temperature induced photoinhibition in bean plants characterized by data analysis of the drop from R- to S-level of the photothermal signal. Bulgarian Journal of Plant Physiology (Special Issue): 336

Fisher, T.E.; Oliet, S.H.R.; Bourque, C.W. 1992: High- and low-threshold calcium currents coexist in magnocellular neurosecretory cells. Society for Neuroscience Abstracts 18(1-2): 431

Churchill, D.; Macvicar, B.A. 1994: High- and low-threshold calcium currents in cultured and acutely-isolated nucleus accumbens neurons. Society for Neuroscience Abstracts 20(1-2): 898

Kattwinkel, J.; Bloom, B.T.; Delmore, P.; Glick, C.; Brown, D.; Lopez, S.; Willett, L. 1998: High- vs low-threshold surfactant re-treatment for neonatal RDS. Pediatric Research 43(4 Part 2): 179A

Graier, W.F.; Simecek, S.; Hoebel, H.G.; Wascher, T.C.; Kostner, G.M. 1996: High-D-glucose-induced changes in endothelial Ca-2+/EDRF signaling is due to generation of superoxide anions. Diabetologia 39(Suppl 1): A139

Berling, R.; Genell, S.; Ohlsson, K. 1994: High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial. Journal of Gastroenterology 29(4): 479-485

Benzina, S.; Altmeyer, A.ïs.; Malek, F.; Dufour, P.; Denis, J.-M.; Gueulette, J.; Bischoff, P. 2008: High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cells. Cancer Letters 264(1): 63-70

Pearson, T.A.; Etherton, T.D.; Moriarty, K.; Reed, R.; Kris Etherton, P.M. 1998: High-MUFA diets with peanuts-peanut butter or peanut oil lower total cholesterol and LDL-C identically to a step 2 diet but eliminate the triglyceride increase. FASEB Journal 12(4): A506

Perez Pena, J.; Hernandez Brito, J.J.; Herrera Melian, J.A.; Collado Sanchez, C.; Van Den Berg, C.M.G. 1994: High-Performance Adsorptive Cathodic Stripping Voltammetry of Nickel and Cobalt in Seawater. Electroanalysis 6(11-12): 1069-1076

Dona, A.M.; Verchere, J.F. 1995: High-Performance liquid chromatography of alditols with indirect photometric detection. Journal of Chromatography A 689(1): 13-21

Murata, H.; Shoji, H.; Oshikara, M.; Harada, K.I.; Suzuki, M.; Kondo, F.; Goto, H. 1995: High-Performance liquid chromatography with chemiluminescence detection of derivatized microcystins. Journal of Chromatography A 693(2): 263-270

Matthews, P.D.; Wurtzel, E.T. 1995: High-throughput microplate format for producing and screening riboprobes from bacterial cells. Biotechniques 18(6): 1000-1002; 1004

Tanimoto, H.; Sato, H.; Kuraishi, C.; Kido, K.; Seguro, K. 1995: High-absorption mineral-containing composition and foods. Official Gazette of the United States Patent and Trademark Office Patents 1178(1): 284

De Jong, J.; Schoemann, V.ér.; Lannuzel, D.; Tison, J.-L.; Mattielli, N. 2008: High-accuracy determination of iron in seawater by isotope dilution multiple collector inductively coupled plasma mass spectrometry (ID-MC-ICP-MS) using nitrilotriacetic acid chelating resin for pre-concentration and matrix separation. Analytica Chimica Acta 623(2): 126-139

Wang, R.; Chait, B.T. 1994: High-accuracy mass measurement as a tool for studying proteins. Current Opinion in Biotechnology 5(1): 77-84

Li, Y.; McIver, R.T.; Hunter, R.L. 1994: High-accuracy molecular mass determination for peptides and proteins by Fourier transform mass spectrometry. Analytical Chemistry 66(13): 2077-2083

Yamanaka, H.; Yakabe, Y.; Saito, K.; Sekijima, M.; Sato, H.; Shirai, T. 2008: High-accuracy prediction of carcinogenicity by global quantitative analysis of post-translational modifications in a 28-day in vivo rat study. Cancer Genomics and Proteomics 5(2): 105-116

Plisova, E.Y.; Balabanova, L.A.; Ivanova, E.P.; Mikhailov, V.V.; Rasskazov, V.A.; Fedosov, Y.V. 1994: High-active alkaline phosphatase from marine bacteria Deleya marina. FAR EAST BRANCH-RUSSIAN ACADEMY OF SCIENCES and AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE Author Bridges of the science between North America and the Russian Far East 2) 294

Maxon, H.R.; Thomas, S.R.; Washburn, L.C.; Hinnefeld, J.D. 1993: High-activity iodine-123 for the diagnostic evaluation of patients with thyroid cancer. Journal of Nuclear Medicine 34(5 Suppl): 42P

Graham, E.; Kubin, J.; Mishra, O.P.; Delivoria Papadopoulos, M. 1998: High-affinity Ca++-ATPase activity in cerebral cortical nuclei of the guinea pig fetus during gestation. Pediatric Research 43(4 Part 2): 48A

Maeda, H.; Ito, K.; Tachikawa, A.; Ellis Davies, G.C.R.; Miyashita, Y.; Kasai, H. 1998: High-affinity Ca2+ buffers play a non-linear Ca2+ signaling in Purkinje neurons. Neuroscience Research Suppl (22): S120

D.G., A.; Toubert, M.E.; Dubois, C.; Krawice, I.; Schlageter, M.H.; Degos, L.; Rain, J.D.; Najean, Y.; Chomienne, C. 1994: High-affinity GM-CSF receptors are modulated during all trans retinoic acid treatment of acute promyelocytic leukemia. British Journal of Haematology 87(Suppl 1): 6

Grant, J.A.; Humbert, M.; Taborda-Barata, L.; Sihra, B.S.; Kon, O.M.; Rajakulasingam, K.; Durham, S.R.; Kay, A.B. 1997: High-affinity IgE receptor Fc epsilon Ri expression in allergic reactions. International Archives of Allergy and Immunology 113(1-3): 376-378

Zanellato, A.; Facci, L.; Dal Toso, R.; Skaper, S.D. 1992: High-affinity NGF receptors on C6 astrocytoma cells Growth-dependent expression. Society for Neuroscience Abstracts 18(1-2): 950

Anderson, K.; Cohn, A.H.; Meissner, G. 1994: High-affinity [3H]PN200-110 and [3H]ryanodine binding to rabbit and frog skeletal muscle. American Journal of Physiology 266(2 Part 1): C462-C466

Janjic, N.; Gold, L. 1997: High-affinity RNA ligands for basic fibroblast growth factor. Official Gazette of the United States Patent and Trademark Office Patents 1199(3): 1964

Daval, J.L.; Doriat, J.F.; Humbert, A.C. 1995: High-affinity adenosine A2 receptor maturation in the rat striatum and their coupling to G proteins. Society for Neuroscience Abstracts 21(1-3): 1781

Krause, C.M.; Conklin, D.S.; Marshall, A.P.; Patterson, J.P.; Tran, D.P.; Iyer, G.; Kostich, W.A.; Sperle, K.; Largent, B.L.; Hartig, P.R.; Fitzgerald, L.W. 1998: High-affinity agonist binding correlates with intrinsic activity at the human serotonin 5-HT2A and 5-HT2C receptors. Society for Neuroscience Abstracts 24(1-2): 1099

Beck-Sickinger, A.G.; Hoffmann, E.; Paulini, K.; Reissig, H.U.; Willim, K.D.; Wieland, H.A.; Jung, G. 1994: High-affinity analogues of neuropeptide y containing conformationally restricted non-proteinogenic amino acids. Biochemical Society Transactions 22(1): 145-149

Showell, G.A.; Bourrain, S.; Neduvelil, J.G.; Fletcher, S.R.; Baker, R.; Watt, A.P.; Fletcher, A.E.; Freedman, S.B.; Kemp, J.A.; Marshall, G.R. 1994: High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group. Journal of Medicinal Chemistry 37(6): 719-721

Lin, Y.n; Nieuwlandt, Daniel; Magallanez, Anna; Feistner, Bruce; Jayasena, Sumedha, D. 1997: High-affinity and specific recognition of human thyroid stimulating hormone by in vitro-selected 2-amino-modified RNA. Journal of Clinical Ligand Assay 20(1): 98-107

Wolins, N.E.; Donaldson, R.P. 1993: High-affinity binding of a peptide bearing the peroxisomal targeting sequence to glyoxysomal membranes. Plant Physiology (Rockville) 102(1 Suppl): 148

Webster, S.G. 1993: High-affinity binding of putative moult-inhibition hormone and crustacean hyperglycaemic hormone to membrane-bound receptors on the Y-organ of the shore crab Carcinus maenas. Proceedings of the Royal Society of London Series B Biological Sciences 251(1330): 53-59

Orchinik, M.; Witt, D.M.; Mcewen, B.S. 1993: High-affinity binding sites for corticosteroids in mammalian brain membranes. Society for Neuroscience Abstracts 19(1-3): 821

Ouwehand, A.J.; Baan, C.C.; Vaessen, L.M.; Balk, A.H.; Jutte, N.H.; Mochtar, B.; Claas, F.H.; Weimar, W. 1993: High-affinity cytotoxic T lymphocytes in the graft of heart transplant patients with rejection. Transplantation Proceedings 25(1 Part 2): 1162-1164

Stephens, R.E.; Prior, G. 1993: High-affinity dynein-like flagellar MAPs are immunologically distinct from dynein heavy chains. Molecular Biology of the Cell 4(Suppl ): 160A

Gegelashvili, G.; Civenni, G.; Racagni, G.; Danbolt, N.; Schousboe, I.; Schousboe, A. 1997: High-affinity glutamate transporters Molecular diversity and regulatory factors. Journal of Neurochemistry 69(Suppl ): S129

Merola, B.; Rossi, E.; Longobardi, S.; Ferone, D.; Selleri, A.; Caruso, E.; Colao, A.; Jaquet, H.; Lombardi, G. 1993: High-affinity growth hormone binding protein in five patients with Turners syndrome. Acta Paediatrica Suppl 1993(388): 127

Zhu, J.; Taniguchi, T.; Konishi, Y.; Mayumi, M.; Muramatsu, I. 1998: High-affinity hemicholinium-3 binding sites in brain membranes of rat neonates Uprelation by nicotine treatment. Japanese Journal of Pharmacology 79(Suppl 1): 184P

Reiser, G. 1993: High-affinity inositol 1,3,4,5-tetrakisphosphate receptor from cerebellum. Fain, J N Methods in Neurosciences; Lipid metabolism in signaling systems 280-297

Sarkadi, B.; Szabo, K.; Mueller, M.; Hegedus, T.; Seprodi, J. 1997: High-affinity interaction of hydrophobic peptide derivates with the human multidrug resistance protein, MDR1. FASEB Journal 11(9): A1154

Bradley, D.C.; Steil, G.M.; Poulin, R.A.; Volund, A.; Bergman, R.N. 1993: High-affinity monomeric insulin analog decreases insulin clearance in conscious dogs. Clinical Research 41(1): 91A

King, V.R.; Xue, J.T.; Spear, P.D. 1994: High-affinity neurotrophin receptor expression in the cat retina during normal development and following neonatal visual cortex damage. Society for Neuroscience Abstracts 20(1-2): 1094

Chen, Z.; Gu, Q.; Giaschi, D.; Cynader, M. 1997: High-affinity neurotrophin receptor immunoreactivity in human retina. Society for Neuroscience Abstracts 23(1-2): 1708

Polisky, B.; Jenison, R.D.; Gold, L. 1996: High-affinity nucleic acid ligands that discriminate between theophylline and caffeine. Official Gazette of the United States Patent and Trademark Office Patents 1193(1): 406

Wiegand, T.W.; Tasset, D.; Gold, L. 1997: High-affinity oligonucleotide ligands to immunoglobulin E. Official Gazette of the United States Patent and Trademark Office Patents 1198(2): 1110

Parma, D.H.; Gold, L. 1997: High-affinity oligonucleotide ligands to secretory phospholipase A2. Official Gazette of the United States Patent and Trademark Office Patents 1197(4): 2550

Nieuwlandt, D.T.; Gold, L.; Wecker, M. 1997: High-affinity oligonucleotide ligands to the tachykinin substance P. Official Gazette of the United States Patent and Trademark Office Patents 1199(2): 1188

Corey, M.; Gersuk, G.; Corey, E.; Stray, J.; Kawasaki, G.; Vessella, R. 1996: High-affinity peptide ligands to PSA identified by polysome selection. Proceedings of the American Association for Cancer Research Annual Meeting 37: 486

Ramanathan, R.; Wright, K.L.; Rodgers, P.; Yu, K.; Huang, C.; Powers, P.; Torkelson, S.; Kidd, D.; Kuo, S.; Schwartz, R.; Elkalay, M.; Reading, C. 1997: High-affinity peptide mimotopes from phage display libraries for CD34 cell isolation. Blood 90(10 Suppl 1 Pt 1): 367A

Latham, P.S.; Verney, E.; Sidransky, H. 1996: High-affinity peripheral benzodiazepine receptors are expressed on nuclei of rat liver cells and a murine macrophage cell line. FASEB Journal 10(3): A145

Schroeder, J.I.; Schachtman, D.P. 1997: High-affinity potassium uptake transporter from higher plants. Official Gazette of the United States Patent and Trademark Office Patents 1196(1): 465

Moore, E.W.; Ostrow, J.D.nald 1996: High-affinity premicellar Ca-2+-binding by the six major bile salts of human bile Kf values are constant, not hyperbolic. Hepatology 24(4 Part 2): 549A

Moore, E.W.; Ostrow, J.D.nald 1996: High-affinity premicellar Ca-2+-binding by the six major bile salts of human bile determined with membrane protected Ca-2+ electrodes not poisoned by BS. Hepatology 24(4 Part 2): 549A

Neri, D.; Winter, G.; Wyder, L.; Klemenz, R.; Neri, G.; Pini, A.; Botti, R.; Neri, P.; Castellani, P.; Carnemolla, B.; Zardi, L. 1996: High-affinity recombinant antibodies against neovasculature and extra-cellular matrix antigens. Immunotechnology 2(4): 267-268

Perregaard, J.; Arnt, J.; Sanchez, C. 1996: High-affinity serotonin 5-HT-1A ligands within a series of 6-substituted 1-indanmethylamines. Society for Neuroscience Abstracts 22(1-3): 1325

Dunlop, J.; Mcilvain, H.B.al 1998: High-affinity sodium-dependent L-glutamate transport in human NT2 neurones. Journal of Neurochemistry 70(Suppl 1): S69

Li, Y.; Chung, T.-S.; Chan, S.Y. 2008: High-affinity sulfonated materials with transition metal counterions for enhanced protein separation in dual-layer hollow fiber membrane chromatography. Journal of Chromatography. a 1187(1-2): 285-288

Aldridge, C.P.; Collard, K.J. 1993: High-affinity uptake of L-arginine by cerebellar and cortical synaptosomes. British Journal of Pharmacology 110(Proceedings Suppl OCT ): 82P

Van Rossum, G.D.V.; Boyd, C.A.R. 1997: High-affinity, Na-dependent uptake of choline by type II cells of rat lung. FASEB Journal 11(3): A562

Sinensky, M.; Siddiqui, A. 1997: High-affinity, saturable, farnesylation-dependent ras binding to plasma membranes. FASEB Journal 11(9): A965

Sachanska, T.; Haralanov, H.; Stamenov, B.; Zlatev, R.; Dimitrov, T. 1995: High-altitude and circulatory hypoxia Main risk factor for pilots during flights. Claussen, C -F , Sakata, E , Itoh, A International Congress Series; Vertigo, nausea, tinnitus and hearing loss in central and peripheral vestibular diseases 273-277

Silveira, F.A.; Cure, J.R. 1993: High-altitude bee fauna of southeastern Brazil Implications for biogeographic patterns. Studies on Neotropical Fauna and Environment 28(1): 47-55

Mocochinski,A.Y.; Scheer,M.B. 2008: High-altitude grasslands on the Serra do MarMountain in Southern Brazil floristic aspects. Floresta: 4, 625-640

Zafren, K.; Honigman, B. 1997: High-altitude medicine. Emergency Medicine Clinics of North America 15(1): 191-222

Hultgren, H.N. 1996: High-altitude pulmonary edema: current concepts. Annual Review of Medicine 47: 267-284

Derks, A.; Bosch, F.H. 1993: High-altitude pulmonary edema in partial anomalous pulmonary venous connection of drainage with intact atrial septum. Chest 103(3): 973-974

Nakagawa, S.; Kubo, K.; Koizumi, T.; Kobayashi, T.; Sekiguchi, M. 1993: High-altitude pulmonary edema with pulmonary thromboembolism. Chest 103(3): 948-950

Aldashev, A.A. 2000: High-altitude pulmonary hypertension and signal transduction in the cardiovascular system. Journal of Receptor and Signal Transduction Research 20(4): 255-278

Perrill, C.V. 1993: High-altitude syncope: history repeats itself. JAMA 269(5): 587

Berglund, B. 1992: High-altitude training. Aspects of haematological adaptation. Sports Medicine 14(5): 289-303

Hafley, J.L.; Bunting, L.D.; Derbigney, M.J.; Sticker, L.S.; Griffin, C.D.Jr 1995: High-amino acid corn, or corn plus urea, corn gluten meal, or fish meal as supplements for cattle fed bermudagrass hay or grazing ryegrass. Journal of Animal Science 73(Suppl 1): 35

Brouillet, F.; Bataille, B.; Cartilier, L. 2008: High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation. International Journal of Pharmaceutics 356(1-2): 52-60

Broad, T. 1994: High-and dry The Tara Hills experience with trees. New Zealand Forestry 38(4): 39-40

Bendtzen, K.; Hansen, M.B.; Ross, C.; Svenson, M. 1998: High-avidity autoantibodies to cytokines. Immunology Today 19(5): 209-211

King, G.D.; Muhammad, A.K.M.Ghulam.; Xiong, W.; Kroeger, K.M.; Puntel, M.; Larocque, D.; Palmer, D.; Ng, P.; Lowenstein, P.R.; Castro, M.G. 2008: High-capacity adenovirus vector-mediated anti-glioma gene therapy in the presence of systemic antiadenovirus immunity. Journal of Virology 82(9): 4680-4684

Putnam, D.D.; Burns, M.A. 1995: High-capacity affinity separation of cell subpopulations using fluidized beds. Abstracts of Papers American Chemical Society 209(1-2): BIOT 109

Carmines, A.A.; Wideman, L.; Weltman, J.Y.; Hartman, M.L.; Weltman, A.; Gaesser, G.A. 1995: High-carbohydrate and high-fat diets do not alter slow component of VO-2 during heavy exercise. Medicine and Science in Sports and Exercise 27(5 Suppl): S9

Ganuza, E.; Anderson, A.J.; Ratledge, C. 2008: High-cell-density cultivation of Schizochytrium sp. in an ammonium/pH-auxostat fed-batch system. Biotechnology Letters 30(9): 1559-1564

Wei, G.; Moreira, A.R. 1997: High-cell-density fermentation of recombinant Escherichia coli expressing a striped bass growth hormone fusion protein. Abstracts of Papers American Chemical Society 213(1-3): BIOT 151

Smertenko, A.P.; Blume, Y.B.; Viklicky, V.; Opatrny, Z.; Draber, P. 1996: High-change heterogeneity of Nicotiana tabacum tubulin. Dopovidi Natsional'noyi Akademiyi Nauk Ukrayiny 1996(9): 142-146

Galletti, F.; D'Elia, L.; Barba, G.; Siani, A.; Cappuccio, F.P.; Farinaro, E.; Iacone, R.; Russo, O.; De Palma, D.; Ippolito, R.; Strazzullo, P. 2008: High-circulating leptin levels are associated with greater risk of hypertension in men independently of body mass and insulin resistance: results of an eight-year follow-up study. Journal of Clinical Endocrinology and Metabolism 93(10): 3922-3926

Harris, M.W.; Harris, W.R. 1996: High-clearance trailers for use in agricultural harvesting of multi-harvest crops. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2618

Garcia, M.L.; Garcia Calvo, M.; Knaus, H.G.; Kaczorowski, G.J.; Lee, S.H.; Mcmanus, O.B. 1993: High-conductance Ca-2+-activated K+ channels Pharmacology and structure. Naunyn-Schmiedeberg's Archives of Pharmacology 348(Suppl): R151

Garcia, M.L.; Hanner, M.; Knaus, H.G.; Kaczorowski, G.J. 1997: High-conductance Ca-2+-activated K+ channels Structure-function analysis. Pfluegers Archiv European Journal of Physiology 434(5 Suppl): R83

Szabo, I.; Bathori, G.; Tombola, F.; Brini, M.; Coppola, A.; Zoratti, M. 1997: High-conductance bacterial channels may mediate the translocation of DNA across membranes. Biophysical Journal 72(2 Part 2): A138

Koch, R.O.A.; Koschak, A.; Wanner, S.G.; Kaczorowski, G.J.; Wittka, R.; Garcia, M.L.; Knaus, H.G.nther 1996: High-conductance calcium-activated potassium channels in rat brain Pharmacological profile, quantification of expression, subunit composition and functional implications. Society for Neuroscience Abstracts 22(1-3): 1754

Simonen, M.; Ibig-Rehm, Y.; Hofmann, G.; Zimmermann, J.; Albrecht, G.; Magnier, M.; Heidinger, V.; Gabriel, D. 2008: High-content assay to study protein prenylation. Journal of Biomolecular Screening 13(6): 456-467

Bin Zhang; Xiubin Gu; Uppalapati, U.; Ashwell, M.A.; Leggett, D.S.; Li, C.J. 2008: High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathways. Journal of Biomolecular Screening 13(6): 538-543

Overk, C.R.; Yao, P.; Chen, S.; Deng, S.; Imai, A.; Main, M.; Schinkovitz, A.; Farnsworth, N.R.; Pauli, G.F.; Bolton, J.L. 2008: High-content screening and mechanism-based evaluation of estrogenic botanical extracts. Combinatorial Chemistry and High Throughput Screening 11(4): 283-293

Conklin, J.; Winter, J.D.; Thompson, R.T.; Gelman, N. 2008: High-contrast 3D neonatal brain imaging with combined T1- and T2-weighted MP-RAGE. Magnetic Resonance in Medicine 59(5): 1190-1196

Raybaud, C.; Girard, N.; Canto Moreira, N.; Poncet, M. 1996: High-definition magnetic resonance imaging identification of cortical dysplasias Micropolygyria versus lissencephaly. Guerrini, R , Canapicchi, R , Zifkin, B G , Andermann, F , Roger, J Dysplasias of cerebral cortex and epilepsy 131-143

Oreto, G.; Calabrò, M.P. 1998: High-degree AV block: what is the mechanism of intermittent conduction?. Journal of Cardiovascular Electrophysiology 9(1): 107-108

Buick, I.S.; Uken, R.; Gibson, R.L.; Wallmach, T. 1998: High-delta super 13 C Paleoproterozoic carbonates from the Transvaal Supergroup, South Africa. Geology 26(10): 875-878

Matsuura, H.; Hirai, A.; Yamada, F.; Matsumoto, T.; Kawai, T. 2008: High-density DNA alignment on an Au(111) surface starting from folded DNA. Journal of the American Chemical Society 130(15): 5002-5003

Ten Caat, M.; Lorist, M.M.; Bezdan, E.; Roerdink, J.B.T.M.; Maurits, N.M. 2008: High-density EEG coherence analysis using functional units applied to mental fatigue. Journal of Neuroscience Methods 171(2): 271-278

Parker, M.L.; Young, E. 1996: High-density apple orchard management techniques evaluated for the southeast Year 5. HortScience 31(5): 749

Shah, N.N.; Hanna, M.L.; Taylor, R.T. 1993: High-density bioreactor cultivation of Methylosinus trichosporium OB3b with hydrogen-driven methane monooxygenase activity. Abstracts of the General Meeting of the American Society for Microbiology 93: 352

Ng, W.L.; Schummer, M.; Bumgarner, R.E.; Cirisano, F.; Baldwin, R.L.; Karlan, B.Y.; Hood, L. 1996: High-density cDNA array expression mapping of human ovarian tumors. Proceedings of the American Association for Cancer Research Annual Meeting 37: 517

Murphy, M.J.; Pettigrew, A.R.; Kilpatrick, W.S.; Dominiczak, M.H. 1997: High-density cholesterol and fibrinogen concentrations in male and female smokers with dyslipidaemia. Clinical Chemistry 43(6 Part 2): S112-S113

Kottkamp, H.; Hindricks, G.; Breithardt, G.; Borggrefe, M. 1998: High-density electro-anatomical non-fluoroscopic catheter mapping of the isthmus in atrial flutter Complete de-novo ablation and specific gap ablation in recurrences. European Heart Journal 19(ABST Suppl ): 535

Triedman, J.K.; Jenkins, K.J.; Colan, S.D.; Saul, J.P.; Walsh, E.P. 1996: High-density endocardial activation mapping of the right atrium in three dimensions by composition of multielectrode catheter recordings. Journal of Electrocardiology 29 Suppl: 234-240

Foxe, J.J.; Simpson, G.V.; Ahlfors, S.P.; Saron, C.D.; Hrabe, J. 1997: High-density evoked-potential recordings reveal active, intermodal attention-switching processes. Society for Neuroscience Abstracts 23(1-2): 1119

JinShuangXi; HanYiBin 2008: High-density fermentation of a Lactobacillus plantarum. Zhongguo Weishengtaxixue Zazhi: 4, 365-366, 368

Southern, E.M. 1996: High-density gridding: techniques and applications. Current Opinion in Biotechnology 7(1): 85-88

Staelens, J.; Rombaut, D.; Vercauteren, I.; Argue, B.; Benzie, J.; Vuylsteke, M. 2008: High-density linkage maps and sex-linked markers for the black tiger shrimp (Penaeus monodon). Genetics 179(2): 917-925

Xiao, G.-L.; Luo, Z.-Q.; Xiao, G.; Li, C.; Xiong, X.-D.; Yang, Y.; Liu, H.-J. 2008: High-density lipoprotein attenuates lipopolysaccharide-induced acute lung injury in mice. Sheng Li Xue Bao: 60(3): 403-408

Lee, R.C.; Pietrobelli, A.; Capristo, E.; Deckelbaum, R.; Heymsfield, S.B. 1998: High-density lipoprotein cholesterol Independent inverse association with adipose tissue-free mass. FASEB Journal 12(5): A685

Pietrobelli, A.; Lee, R.C.; Deckelbaum, R.H.; Heymsfield, S.B. 1998: High-density lipoprotein cholesterol Independent inverse association with non-adipose body mass. International Journal of Obesity 22(Suppl 3): S216

Kitamura, A.; Iso, H.; Naito, Y.; Iida, M.; Konishi, M.; Folsom, A.R.; Sato, S.; Kiyama, M.; Nakamura, M.; Sankai, T. 1994: High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 89(6): 2533-2539

Mayurasakorn, K.; Srisura, W.; Sitphahul, P.; Hongto, P-orn. 2008: High-density lipoprotein cholesterol changes after continuous egg consumption in healthy adults. Journal of the Medical Association of Thailand 91(3): 400-407

Alber, H.F.; Wanitschek, M.M.; de Waha, S.; Ladurner, A.; Suessenbacher, A.; Dörler, J.; Dichtl, W.; Frick, M.; Ulmer, H.; Pachinger, O.; Weidinger, F. 2008: High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. European Journal of Clinical Investigation 38(6): 372-380

Patsch, W.; Gotto, A.M. 1995: High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: pathophysiology and management. Advances in Pharmacology 32: 375-426

Miwa, K.; Inoue, H. 1997: High-density lipoprotein particles are large and cholesterol-rich in patients with variant angina. Japanese Circulation Journal 61(7): 585-586

Monte, G.; Melissari, E.; Kakkar, V.V. 1992: High-density lipoprotein pre- and postvenous occlusion. Miyai, K, Kanno, T, Ishikawa, E International Congress Series; Progress in clincal biochemistry: 465-466

England, B.; Benghuzzi, H. 1994: High-density lipoprotein response to long-term sustained delivery of androgens in castrated rams. FASEB Journal 8(4-5): A576

Jones, R.M. 1995: High-density lipoprotein solid-phase precipitation assay device. Official Gazette of the United States Patent and Trademark Office Patents 1178(3): 1625

Skinner, E.R. 1994: High-density lipoprotein subclasses. Current Opinion in Lipidology 5(3): 241-247

Bagdade, J.D. 1993: High-density lipoprotein transport in diabetes mellitus. Draznin, B, Eckel, R H Diabetes and atherosclerosis: Molecular basis and clinical aspects 59-76

Barter, P. 1993: High-density lipoproteins and reverse cholesterol transport. Current Opinion in Lipidology 4(3): 210-217

Kirchhof, C.J.H.; Saltman, A.E.; Krukenkamp, I.B.; Campos, C.T.; Cohn, W.; Lahey, S.J.; Levitsky, S.; Josephson, M.E. 1996: High-density mapping of chronic atrial fibrillation in man. Circulation 94(8): I744-I745

Sheffield, V.C.; Sunden, S.L.F.; Alward, W.L.M.; Rohklina, T.R.; Nichols, B.E.; Stone, E.M. 1996: High-density mapping of the juvenile open angle glaucoma region. IOVS Investigative Ophthalmology and Visual Science 37(3): S457

Ghannam, A.; Hammache, D.; Matias, C.; Louwagie, M.; Garin, Jérôme.; Gerlier, D. 2008: High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation. Molecular Immunology 45(11): 3036-3044

Triedman, J.K.; Jenkins, K.J.; Colan, S.D.; Saul, J.P.; Walsh, E.P. 1996: High-density transcatheter mapping shows diverse mechanisms for atrial reentrant tachycardia after congenital heart surgery. Journal of the American College of Cardiology 27(2 Suppl A): 189A

Ng, D.S.; Hegele, R.A. 1993: High-density-lipoprotein cholesterol and atherosclerosis. Cmaj: Canadian Medical Association Journal 149(12): 1807-1808

Pieramico, O.; Zanetti, M.V.; Innerhofer, M. 1998: High-dosage omeprazole-based triple therapy for the eradication of H pylori infection A randomized trial. Gastroenterology 114(4 Part 2): A258

Schrier, D.M.; Stemmer, S.M.; Johnson, T.; Kasliwal, R.; Lear, J.; Matthes, S.; Taffs, S.; Dufton, C.; Glenn, S.D.; Butchko, G.; Ceriani, R.L.; Rovira, D.; Bunn, P.; Shpall, E.J.; Bearman, S.I.; Purdy, M.; Cagnoni, P.; Jones, R.B. 1995: High-dose 90Y Mx-diethylenetriaminepentaacetic acid -BrE-3 and autologous hematopoietic stem cell support for the treatment of advanced breast cancer A phase I trial. Cancer Research 55(23 Suppl): 5921S-5924S

Braith, R.W.; Mills, R.M.; Wilcox, C.S.; Davis, G.L.; Wood, C.E. 1998: High-dose ACE inhibition normalizes renal salt and water handling in heart transplant recipients. Circulation 98(17): I378

Becton, D.L.; Weinstein, H.J.; Ogden, A.; Berkow, R.; Krischer, J. 1993: High-dose ARA-C , daunorubicin , thioguanine , and VP-16 for remission induction in untreated AML in children. Blood 82(10 Suppl 1): 195A

Buccisano, F.; Del Poeta, G.; Venditti, A.; Tamburini, A.; Cantonetti, M.; Cudillo, L.; Aronica, G.; Cordero, V.; Morino, L.; Maurillo, L.; Masi, M.; Amadori, S. 1998: High-dose ARAC/mitoxantrone followed by stem cell transplantation for the treatment of poor-risk lymphoid malignancies. British Journal of Haematology 102(1): 229

Mehta, J.; Powles, R.; Treleaven, J.; Singhal, S.; Horton, C.; Milan, S.; Catovsky, D. 1994: High-dose Ara-C and VP-16 with or without idarubicin for induction of remission in untreated primary acute myeloid leukemia. Blood 84(10 Suppl 1): 145A

Aisen, P.S.; Schneider, L.S.; Sano, M.; Diaz-Arrastia, R.; van Dyck, C.H.; Weiner, M.F.; Bottiglieri, T.; Jin, S.; Stokes, K.T.; Thomas, R.G.; Thal, L.J.; Vicari, S.; Ala, T.; Luster, K.; Quinn, J.; Lear, J.; Clay, T.; Schneider, L.S.; Pawluczyk, S.; Dagerman, K.; Sian, S.; Fleisher, A.; Pay, M.M.; Barbas, N.; Lord, J.; Peskind, E.; Raskind, M.A.; Mandelco, L.; Doody, R.S.; Sims, J.; Roundtree, S.; Bell, K.; Tejeda, R.; Dominguez-Rivera, E.; Harrell, L.; Marson, D.; Zamrini, E.; Grossman, H.; Marzloff, G.; Nandipait, S.; Aggarwal, N.; Shah, R.; Bach, J.; P 2008: High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300(15): 1774-1783

Suliman, M.E.; Divino Filho, J.C.; Barany, P.; Anderson, B.; Lindholm, B.; Bergstrom, J. 1998: High-dose B6 and folic acid have no effects on abnormality of methionine loading test in hemodialysis patients. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 162A

Linassier, C.; Frappaz, D.; Cure, H.; Van Praagh, I.; Biron, P.; Calais, G.; Jan, M.; Plagne, R.; Benboubker, L.; Colombat, P. 1998: High-dose BCNU in patients after complete resection of glioblastoma multiforme Retrospective results in 107 patients from 3 French centers. Bone Marrow Transplantation 22(Suppl 3): S72-S74

Linassier, C.; Benboubker, L.; Velut, S.; Calais, G.; Saudeau, D.; Jan, M.; Autret, A.; Berger, C.; Biron, P.; Colombat, P. 1996: High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme. Bone Marrow Transplantation 18(Suppl 1): S69-S72

Koeppler, H.; Gehling, U.; Heymanns, J.; Pflueger, K.H.; Havemann, K. 1993: High-dose CVB or BEAM followed by non-cryopreserved autologous bone marrow transplantation for poor prognosis high grade non-Hodgkins lymphoma. Annals of Hematology 67(Suppl ): A68

Buccisano, F.; Del Poeta, G.; Venditti, A.; Tamburini, A.; Cantonetti, M.; Cudillo, L.; Aronica, G.; Cordero, V.; Dentamaro, T.; Picardi, A.; Postorino, M.; Rainaldi, A.; Morino, L.; Masi, M.; Amadori, S. 1997: High-dose Cytarabine combined with high-dose Mitoxantrone for the treatment of poor-risk lymphoid malignancies. Blood 90(10 Suppl 1 Pt 2): 238B

Jennis, A.; Pecora, A.; Preti, R.; Murphy, L.; Goldberg, S.; Cantwell, S. 1998: High-dose G-CSF stem cell mobilization after initial stem cell mobilization failure. Blood 92(10 Suppl 1 Part 1-2): 271A

Yoong, K.F.; Adams, D.H. 1997: High-dose IL-2 reverses functional deficiency and restores CD3-zeta chain expression in T-cells isolated from human malignant liver tumours. Journal of Hepatology 26(Suppl 1): 114

Yoong, K.F.; Adams, D.H. 1997: High-dose IL-2 reverses the functional defect and restores CD3-zeta chain expression in tumor-infiltrating lymphocytes isolated from human malignant liver tumours. Gastroenterology 112(4 Suppl): A686

Sparano, J.A.; Dutcher, J.P. 1993: High-dose IL-2 treatment of melanoma. Atkins, M B, Mier, J W Basic and Clinical Oncology; Therapeutic applications of interleukin-2: 99-117

Sunderland, M.C.; Weiss, G.R. 1993: High-dose IL-2 treatment of renal cell carcinoma. Atkins, M B, Mier, J W Basic and Clinical Oncology; Therapeutic applications of interleukin-2: 119-142

Kobbe, G.; Huenerliturkoglu, A.; Bauser, U.; Soehngen, D.; Schneider, P.; Hollenberg, A.N.; Germing, U.; Thiele, K.P.; Meckenstock, G.; Rieth, C.; Fischer, J.; Wernet, P.; Aul, C.; Heyll, A. 1998: High-dose MTX based polychemotherapy according to the GMALL B-ALL protocol to induce remission and mobilize CD34+ cells in patients with advanced NHL. Annals of Hematology 77(Suppl 2): S162

Grewe, M.; Gyufko, K.; Block, R.; Parlow, F.; Schoepf, E.; Krutmann, J. 1993: High-dose UVA therapy differentially affects transcript levels of interferon gamma and interleukin -4 in lesional atopic skin. Journal of Investigative Dermatology 100(4): 597

Stege, H.; Krutmann, J. 1997: High-dose UVA1 therapy. Photochemistry and Photobiology 65(SPEC ISSUE): 56S

Stege, H.; Humke, S.; Berneburg, M.; Dierks, K.; Mueller Forte, S.; Goerz, G.; Ruzicka, T.; Krutmann, J. 1996: High-dose UVA1 therapy in the treatment of patients with localized scleroderma. Journal of Investigative Dermatology 106(4): 845

Mross, K.; Reifke, J.; Bewermeier, P.; Krueger, W.; Stockschlaeder, M.; Zander, A.; Hossfeld, D.K. 1995: High-dose VP-16 The toxicity is not correlated to the area under the curve but to the schedule. Onkologie 18(Suppl 2): 57

Brugger, W.; Subklewe, M.; Scheding, S.; Schlimok, G.; Mertelsmann, R.; Brugger, W.; Kanz, L. 1995: High-dose VP16, ifosfamide, carboplatin, and epirubicin with peripheral blood progenitor cell transplantation in patients with high-risk stage II/III breast cancer. Onkologie 18(Suppl 2): 52

Reyes, E.; Loong, C.Y.; Harbinson, M.; Donovan, J.; Anagnostopoulos, C.; Underwood, S.R. 2008: High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. Journal of the American College of Cardiology 52(24): 2008-2016

Inagaki, A.; Iwase, K.; Maruyama, F.; Ohtani, S.; Tsujimura, T.; Jimbo, S.; Miura, K. 1994: High-dose adjuvant chemotherapy with peripheral blood stem cel transplantation for advanced breast cancer. International Journal of Oncology 5(Suppl ): 402

Ahmed, T.; Razis, E.; Cook, P.; Beer, M.; Lake, D.E.; Preti, R.A.; Ali, M.; Mittelman, A. 1994: High-dose adjuvant treatment with autologous bone marrow transplant for high-risk breast cancer. Journal of Cellular Biochemistry Suppl 1994(18B): 94

Somlo, G.; Doroshow, J.H.; Synold, T.; Chow, W.; Hamasaki, V.; Leong, L.; Margolin, K.; Morgan, R.; Raschko, J.; Forman, S.; Shibata, S.; Tetef, M.; Yen, Y. 1996: High-dose adriamycin , cyclophosphamide and paclitaxel for patients with high-risk and responsive stage IV breast cancer. Breast Cancer Research and Treatment 41(3): 276

Wetzel, H.; Philipp, M.; Gattaz, W.F.; Sauer, H.; Adler, G.; Hillert, A.; Benkert, O.; Group, A.S.udy 1995: High-dose amisulpride versus flupentixol in Schizophrenia with predominantly positive symptomatology. Pharmacopsychiatry 28(5): 227

Bicanic, T.; Wood, R.; Meintjes, G.; Rebe, K.; Brouwer, A.; Loyse, A.; Bekker, L.-G.; Jaffar, S.; Harrison, T. 2008: High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(1): 123-130

Dodge, R.A.; Daly, J.S.; Davaro, R.; Glew, R.H. 1997: High-dose ampicillin plus streptomycin for treatment of a patient with severe infection due to multiresistant enterococci. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 25(5): 1269-1270

Paton, C.; Barnes, T.R.E.; Cavanagh, M-Rose.; Taylor, D.; Lelliott, P.; Antoniou, J.; Hancock, E.; Hutchison, M. 2008: High-dose and combination antipsychotic prescribing in acute adult wards in the UK: the challenges posed by p.r.n. prescribing. British Journal of Psychiatry: the Journal of Mental Science 192(6): 435-439

Barbera, C.; Bortolotti, F.; Coscia, A.; Crivellaro, C.; Zancan, L.; Cadrobbi, P.; Pillan, N.; Nebbia, G.; Lepore, L.; Brunetto, M.; Bonino, F. 1993: High-dose and low-dose recombinant alpha IFN therapy in children with chronic hepatitis B. Journal of Hepatology 18(Suppl 1): S93

Mohr, R.; Medalion, B.; Shinfeld, A.; Shinar, E.; Lavee, J. 1993: High-dose aprotinin improves hemostasis after open heart better than transfusion of single donor platelet concentrate. Circulation 88(4 Part 2): I265

Capedevila, X.; Biboulet, P.; Calvet, Y.; D'athis, F.; Du Cailar, J. 1994: High-dose aprotinin reduces blood loss and homologous transfusion in patients undergoing septic or tumor orthopedic surgery. Anesthesiology 81(3A): A89

Andreotti, F.; Davies, G.J.; Ujang, S.B.; Sritara, P.; Kluft, C.; Maseri, A. 1993: High-dose aspirin, thrombin, and coronary angioplasty. Lancet 341(8853): 1161

Geissler, H.J.; Davis, K.L.; Allen, S.J.; Buja, L.M.; Laine, G.A.; Mehihorn, U.; De Vivie, E.R. 1998: High-dose beta-blockade during reperfusion only reduces ischemia-reperfusion injury. FASEB Journal 12(5): A711

Verheugt, Freek W.A.; Marsh, Randall C.; Veen, Gerrit; Galjee, Michel A.; De Cook, Carel C.; Bronzwaer, Jean G.F. 1994: High-dose bolus heparin alone as primary reperfusion therapy for acute transmural myocardial infarction Preliminary results of the ongoing angiographic HEAP pilot study. Circulation 90(4 Part 2): I563

Zimmerman, T.M.; Grad, G.I.; Grinblatt, D.L.; Michelson, G.C.; Williams, S.F. 1996: High-dose busulfan , VP-16, and ARA-C with peripheral blood progenitor cell support for patients with refractory and relapsed Hodgkins and non-Hodgkins lymphoma. Blood 88(10 Suppl 1 Part 1-2): 124A

Seay, T.E.; Devine, S.M.; Geller, R.T.; Heffner, L.T.; Hillyer, C.; Holland, H.K.; Rodey, G.E.; Saral, R.; Vogler, W.R. 1993: High-dose busulfan , VP-16, cytoxan with marrow rescue for multiple myeloma. Blood 82(10 Suppl 1): 578A

Lee, H.B.; Park, S.S.; Kim, M.; Han, H.S.; Oh, D.; Kim, C.S.; Park, S. 1998: High-dose busulfan administration induces collagen mRNA expression in rat hepatocytes within one day. Blood 92(10 Suppl 1 Part 1-2): 288B

Lee, H.B.; Park, S.S.; Oh, D.; Kim, C.S.; Park, S. 1997: High-dose busulfan administration stimulates collagen type I and III synthesis in rat hepatocytes. Blood 90(10 Suppl 1 Pt 2): 316B

Kalifa, C.; Hartmann, O.; Vassal, G.; Mechinaud, F.; Valteau, D.; Brugieres, L.; Habrand, J.L.; Lemerle, J. 1993: High-dose busulfan and thiotepa with autologous bone marrow transplantation as a salvage therapy for nonirradiated medulloblastoma patients. Pediatric Neurosurgery 19(6): 318-319

Teinturier, C.; Hartmann, O.; Valteau Couanet, D.; Benhamou, E.; Bougneres, P.F. 1998: High-dose busulfan is a major cause of ovarian failure. Hormone Research (Basel) 50(Suppl 3): 113

Holmberg, L.A.; Demirer, T.; Rowley, S.; Buckner, C.D.; Goodman, G.; Maziarz, R.; Klarnet, J.; Zuckerman, N.; Harrer, G.; Mccloskey, R.; Gersh, R.; Goldberg, R.; Nichols, W.; Jacobs, A.; Weiden, P.; Montgomery, P.; Rivkin, S.; Appelbaum, F.R.; Bensinger, W.I. 1998: High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell rescue in patients with advanced stage III/IV ovarian cancer. Bone Marrow Transplantation 22(7): 651-659

Holmberg, L.A.; Demirer, T.; Sciffman, K.; Rowley, S.C.; Buckner, C.D.; Goodman, G.; Maziari, R.; Appelbaum, F.; Bensinger, W.I. 1997: High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cells rescue in patients with advanced stage III/IV ovarian cancer. Blood 90(10 Suppl 1 Pt 1): 383A

Adler Reichel, S.; Langenmayer, I.; Oduncu, F.; Christgau, H.; Beyer, C.; Kaspar, M.; Nerl, C.; Enne, W.; Emmerich, B.; Starka, C. 1998: High-dose busulfan/cyclophosfamide followed by autologous blood stem cell transplantation in patients with relapsed lymphoma. Annals of Hematology 77(Suppl 2): S159

Badell, I.; Pardo, N.; Torrent, M.; Garcia, J.; Ayats, R.; Martino, R.; Farre, R.; Mangues, M.A.; Cubells, J. 1996: High-dose busulphan and melphalan as conditioning regimen in ABMT for acute non lymphoblastic leukemia in ten children. Bone Marrow Transplantation 18(Suppl 2): 69

Shea, T.C.; Mason, J.R.; Storniolo, A.M.; Bissent, E.; Breslin, M.; Mullen, M.; Taetle, R. 1993: High-dose carboplatin chemotherapy with GM-CSF and peripheral blood progenitor cell support: a model for delivering repeated cycles of dose-intensive therapy. Cancer Treatment Reviews 19 Suppl C: 11-20

Siegert, W.; Beyer, J.; Strohscheer, I.; Schwaner, I.; Moumen, A.; Zimmerman, R.; Schmoll, H.J.; Huhn, D. 1994: High-dose carboplatin etoposide and ifosfamide followed by autologous stem cell transplantation in poor prognosis testicular cancer. Journal of Cancer Research and Clinical Oncology 120(Suppl ): R124

Mason, J.; Ho, A.; Mullen, M.; Young, D.; Shea, T. 1993: High-dose carboplatin with peripheral blood stem cells and sequential interleukin-3 and GM-CSF. Blood 82(10 Suppl 1): 365A

Kleiner, S.; Beyer, J.; Krause, M.; Schwella, N.; Schwaner, I.; Baumann, H.; Huhn, D.; Siegert, W. 1995: High-dose carboplatin, etoposide and ifosfamide in lymphomas and germ cell tumors A follow-up on toxicity. Onkologie 18(Suppl 2): 109

Briggs, G.G.; Ambrose, P.J.; Nageotte, M.P.; Padilla, G. 2008: High-dose carisoprodol during pregnancy and lactation. Annals of PharmacoTherapy 42(6): 898-901

Ager, S.; Mahendra, P.; Bass, G.; Richards, M.; Marcus, R.E. 1994: High-dose carmustine, etoposide and melphalan with autologous stem cell transplantation; A dosetoxicity study. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 101

Li, W.; Lu, L.; Li, Y.; Fu, F.; Fung, J.J.; Thomson, A.W.; Qian, S. 1997: High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation. Transplantation Proceedings 29(1-2): 1081-1082

Humblet, Y.; Bosquée, L.; Weynants, P.; Symann, M. 1996: High-dose chemo-radiotherapy cycles for LD small cell lung cancer patients using G-CSF and blood stem cells. Bone Marrow Transplantation 18(Suppl 1): S36-S39

Molina, A.; Nademanee, A.; O'donnell, M.R.; Snyder, D.S.; Stein, A.S.; Parker, P.M.; Smith, E.P.; Lee, J.; Planas, I.; Kashyap, A.; Spielberger, R.T.; Margolin, K.; Somlo, G.; Kapoor, N.; Chow, W.; Vora, N.; Sniecinski, I.; Niland, J.; Forman, S.J. 1996: High-dose chemo/radiotherapy and G-CSF primed peripheral blood stem cell transplantation in follicular low grade and transformed lymphoma. Blood 88(10 Suppl 1 Part 1-2): 121A

Vose, J.M. 1993: High-dose chemoradiotherapy and autologous transplantation in non-Hodgkins lymphoma. Kimura, K , Yamada, K , Carter, S K , Longo, D L International Congress Series; Cancer chemotherapy: Challenges for the future, Vol 8 : 295-303

Schenkein, D.P.; Koc, Y.; Alcindor, T.; Stadtmauer, E.A.; Miller, K.B.; Lazarus, H.M. 1998: High-dose chemoradiotherapy and peripheral stem cell rescue for primary resistant or recurrent myeloma Long-term follow-up of phase I-II study. Blood 92(10 Suppl 1 Part 1-2): 663A

Corradini, P.; Voena, C.; Astolfi, M.; Ladetto, M.; Tarella, C.; Boccadoro, M.; Pileri, A. 1994: High-dose chemoradiotherapy in multiple myeloma Residual tumor cells are detectable in bone marrow and peripheral blood cell harvests and after autografting. Blood 84(10 Suppl 1): 399A

Huebsch, L.; Leger, C.; Bredeson, C.; Bumell, M.; Butts, C.; Genest, P.; Giulivi, A.; Markman, S.; Mcdiamid, S.; Van Der Jagt, R. 1994: High-dose chemoradiotherapy with unpurged marrow and/or blood stem cell support for follicular non-Hodgkins lymphoma. Blood 84(10 Suppl 1): 208A

Holstein, K.; De Wit, M.; Hossfeld, D.K. 1998: High-dose chemotherapy Application of G-CSF after stem cell support does not seem to reduce cost of supportive care and length of hospital stay. Annals of Hematology 77(Suppl 2): S199

Bertetto, O.; Clerico, M. 1998: High-dose chemotherapy Working new treatment schedules to optimize response to therapy. Anticancer Research 18(6C): 4845

Strohscheer, I.; Beyer, J.; Baurmann, H.; Oettle, H.; Kleiner, S.; Schwella, N.; Zimmermann, R.; Siegert, W. 1993: High-dose chemotherapy and ABMT in three patients with relapse of mediastinal large-B-cell Lymphoma with sclerosis. Annals of Hematology 67(Suppl ): A124

Siegert, W.; Beyer, J. 1996: High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up. Bone Marrow Transplantation 18(Suppl 1): S60

Arseniev, L.; Bokemeyer, C.; Andres, J.; Koenneke, A.; Papageorgiou, E.; Kleine, H.D.; Battmer, K.; Suedmeyer, I.; Zaki, M. 1992: High-dose chemotherapy and GM- or G-CSF for mobilization of peripheral blood stem cells in patients with non-seminomatous germ cell tumors. Annals of Hematology 65(Suppl ): A31

Corradini, P.; Astolfi, M.; Caracciolo, D.; Bondesan, P.; Cherasco, C.; Pileri, A.; Tarella, C. 1995: High-dose chemotherapy and PBPC autografting in low- and intermediate-grade B-cell lymphomas Analysis of minimal residual disease and molecular follow-up. Blood 86(10 Suppl 1): 810A

Corradini, P.; Astolfi, M.; Voena, C.; Caracciolo, D.; Vitolo, U.; Benedetti, F.; Pileri, A.; Tarella, C. 1998: High-dose chemotherapy and PBPC autografting induce durable molecular remissions in follicular lymphomas, but not in small lymphocytic and mantle cell lymphomas. Blood 92(10 Suppl 1 Part 1-2): 463A

Corradini, P.; Astolfi, M.; Caracciolo, D.; Bondesan, P.; Cherasco, C.; Pileri, A.; Tarella, C. 1996: High-dose chemotherapy and PBPO autografting in follicular and mantle cell lymphomas Analysis of minimal residual disease and molecular follow-up. British Journal of Haematology 93(Suppl 2): 365

McGuire, W.P. 1998: High-dose chemotherapy and autologous bone marrow or stem cell reconstitution for solid tumors. Current Problems in Cancer 22(3): 135-177

Stahel, R.A.; Jost, L.M.; Pichert, G.; Widmer, L. 1995: High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas. Cancer Treatment Reviews 21(1): 3-32

Kiefer, T.; Kalusche, E.M.; Brugger, W.; Kanz, L.; Doelken, G. 1995: High-dose chemotherapy and autologous peripheral blood stem cell rescue in refractory or relapsed nonseminomatous germ cell tumors. Onkologie 18(Suppl 2): 109

Dillman, R.O.; Barth, N.M.; Vandermolen, L.A.; Mahdavi, K.; Nayak, S.K. 1997: High-dose chemotherapy and autologous stem cell rescue in hematologic malignancies Single institution experience. Blood 90(10 Suppl 1 Pt 2): 401B

Dillman, R.O.; Barth, N.M.; Vandermolen, L.A.; Simpson, L.; O'connor, A.A.; Nayak, S.K. 1998: High-dose chemotherapy and autologous stem cell rescue in metastatic breast cancer Patients who undergo tandem transplants have a superior survival outcome compared to patients who undergo a single transplant. Blood 92(10 Suppl 1 Part 1-2): 363B

Popescu, R.A.; Cunningham, D. 1997: High-dose chemotherapy and autologous stem cell transplantation in 3 patients with lymphomatous polyposis. British Journal of Cancer 76(Suppl 1): 53

Cure, H.; Legros, M.; Fleury, J.; Dauplat, J.; Condat, P.; Choufi, B.; Chollet, P.; Plagne, R. 1996: High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer. Bone Marrow Transplantation 18(Suppl 1): S34-S35

Uppenkamp, M.; Boeck, H.P.; Hense, J.; Meusers, P.; Brittinger, G. 1996: High-dose chemotherapy and autologous stem cell transplantation in patients with high-grade non-Hodgkin lymphoma Results of a prospective study. Annals of Hematology 73(Suppl 2): A111

Siegert, W.; Beyer, J.; Schwaner, I.; Kirsch, A.; Lorenz, F.; Schwella, N.; Strohscheer, I.; Oettle, H.; Schmoll, H.J.; Bokemeyer, C.; Huhn, D. 1994: High-dose chemotherapy and autologous stem cell transplantation in refractory or relapsed germ cell tumors. Bone Marrow Transplantation 14(Suppl 1): S44

Blay, J.Y.; Bouhour, D.; Brunat Mentigny, M.; Rivoire, M.; Philip, I.; Philip, T.; Biron, P. 1994: High-dose chemotherapy and bone marrow support in advanced sarcomas. Bone Marrow Transplantation 14(Suppl 1): S55

Bafaloukos, D. 1996: High-dose chemotherapy and haematopoietic growth factor support in advanced ovarian cancer. European Journal of Gynaecological Oncology 17(5): 443-445

Kotz, K.W.; Schilder, R.J. 1995: High-dose chemotherapy and hematopoietic progenitor cell support for patients with epithelial ovarian cancer. Seminars in Oncology 22(3): 250-262

Baynes, R.D.; Klein, J.L.; Dansey, R.D.; Karanes, C.; Abella, E.; Akhtar, A.; Cassels, L.; Peters, W.P. 1998: High-dose chemotherapy and hematopoietic stem cell rescue for metastatic and high-risk primary breast cancer. Bone Marrow Transplantation 22(Suppl 3): S87-S90

Oriol, A.; Ribera, J.-M.; Bergua, J.; Giménez Mesa, E.; Grande, C.; Esteve, J.; Brunet, S.; Moreno, M.-J.; Escoda, L.; Hernandez-Rivas, J.-M.; Hoelzer, D. 2008: High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer 113(1): 117-125

Dillman, R.O.; Barth, N.M.; Vandermolen, L.; Nayak, S.K.; O'connor, A.; Beutel, L.; Morrelli, L. 1996: High-dose chemotherapy and peripheral blood stem cell rescue in breast cancer. Breast Cancer Research and Treatment 41(3): 278

Vredenburgh, J.J.; Ross, M.; Hussein, A.; BastRobert, C.Jr; Shpall, E.J.; Tyer, C.; Peters, W.P. 1994: High-dose chemotherapy and purged autologous bone marrow support for patients with metastatic breast cancer. Journal of Cellular Biochemistry Suppl 1994(18B): 57

Carella, A.M. 1997: High-dose chemotherapy and radiotherapy followed by autotransplantation of Ph-negative hemopoietic cell-precursors in patients with chronic myelogenous leukemia. Gematologiya i Transfuziologiya 42(3): 6-7

Schmitz, N. 1994: High-dose chemotherapy and stem cell rescue in Hodgkins disease. Journal of Cancer Research and Clinical Oncology 120(Suppl ): R124

Miser, J.S.; Sanders, J.E. 1994: High-dose chemotherapy and systemic adjuvant irradiation in Ewings sarcoma. Bone Marrow Transplantation 14(Suppl 1): S54

Khouri, I.F.; Kantarjian, H.M.; Talpaz, M.; Rios, M.B.; Giralt, S.; Hester, J.P.; Champlin, R.E.; Deisseroth, A.B. 1994: High-dose chemotherapy and unpurged autologous stem cell transplantation for chronic myelogenous leukemia The MD Anderson experience. Blood 84(10 Suppl 1): 537A

Schmoor, C.; Schumacher, M. 1996: High-dose chemotherapy as adjuvant treatment for breast cancer Some statistical arguments. Onkologie 19(1): 78-80

Pico, J.L.; Castagna, L.; Kramar, A.; Biron, P.; Bouzy, J.; Rosti, G. 1996: High-dose chemotherapy as salvage treatment for germ cell tumors. the ongoing IT94 study. Bone Marrow Transplantation 18(Suppl 1): S63-S66

Wiedemann, G.; Knop, E.; Eleftheriadis, S.; Wagner, T. 1993: High-dose chemotherapy combined with whole-body-hyperthermia in advanced disseminated malignancies A phase I trial. Annals of Hematology 67(Suppl ): A135

Jonas, C.R.; Puckett, A.B.; Kurtz, J.C.; Griffith, D.P.; Newman, M.L.; Furr, C.E.; Galloway, J.L.; Jones, D.P.; Ziegler, T.R. 1997: High-dose chemotherapy decreases plasma glutathione in patients undergoing bone marrow transplantation. FASEB Journal 11(3): A649

Rohwedder, E.B.; Dreger, P.; Suttorp, M.; Kloess, H.; Loeffler, M.; Loeffler, H.; Schmitz, N. 1995: High-dose chemotherapy followed by autologous stem cell transplantation for 99 patients with relapsed or refractory Hodgkins disease. Onkologie 18(Suppl 2): 43

Schmitz, N. 1993: High-dose chemotherapy followed by hematopoietic stem cell rescue in patients with Hodgkins disease. Annals of Hematology 67(Suppl ): A110

Freund, M.; Kahrs, M.; Heussner, P.; Petershofen, E.K.; Schoeffski, P.; Andres, J.; Arseniev, L.; Link, H.; Poliwoda, H. 1995: High-dose chemotherapy followed by reinfusion of autologous peripheral stem cells Salvage measure or alternative for bone marrow transplantation?. Diehl, V , Schlag, R , Thiel, E Hodgkin's disease and non-Hodgkin's lymphoma: Progress in diagnosis and current therapy strategies Morbus Hodgkin und Non-Hodgkin-Lymphoma: Fortschritte der Diagnostik und aktuelle Therapiekonzepte 117-125

Freund, M.; Kahrs, M.; Heussner, P.; Petershofen, E.K.; Schoeffski, P.; Andres, J.; Arseniev, L.; Link, H.; Poliwoda, H. 1998: High-dose chemotherapy followed by reinfusion of autologous peripheral stem cells Salvage measure or alternative to bone marrow transplantation. Diehl, V , Schlag, R , Thiel, E Hodgkin's disease and non-hodgkin's lymphoma: Advances in diagnosis and current treatment concepts Morbus Hodgkin und Non-hodgkin-Lymphome: Fortschritte der Diagnostik und aktuelle Therapiekonzepte 110-118

Chabannon, C.; Viens, P.; Camerlo, J.; Gravis, G.; Faucher, C.; Novakovitch, G.; Cornetta, K.; Lotz, J.P.; Marolleau, J.P.; Rosenfeld, C.; Chabbert, L.; Mannoni, P.; Maraninchi, D.; Mills, B.; Oldham, F.; Blaise, D. 1995: High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor risk breast cancer A randomized multicenter study. Blood 86(10 Suppl 1): 940A

Motzer, R.J. 1996: High-dose chemotherapy for germ cell tumors Memorial Sloan Kettering Cancer Center. Bone Marrow Transplantation 18(Suppl 1): S53-S54

Motzer, R.J. 1998: High-dose chemotherapy for germ cell tumors at the Memorial Sloan-Kettering Cancer Center. Bone Marrow Transplantation 22(Suppl 3): S40-S42

Peters, W.P.; Dansey, R.; Klein, J.; Berry, D. 1997: High-dose chemotherapy for high-risk primary breast cancer. Salmon, S E Adjuvant Therapy of Cancer 117-122

Roman-Unfer, S.; Bitran, J.D. 1996: High-dose chemotherapy for malignancies: a review. Comprehensive Therapy 22(2): 107-120

Ochoa, G.; Sobrevilla Calvo, P.; Cervera, E.; Labardini, J.; Reynoso, E.; Salina, V. 1996: High-dose chemotherapy for non-Hodgkins lymphoma and Hodgkin disease with ifosfamide, carboplatin and etoposide , plus hematopoietic rescue with autologous peripheral blood stem cells. Blood 88(10 Suppl 1 Part 1-2): 285B

Marino, P.; Roché, H.; Moatti, J-Paul.; Pouillard, P.; Biron, P.; Spielmann, M.; Janvier, M.; Spaeth, D.; Fabbro, M.; Linassier, C.; Delozier, T.; Curé, H.; Mauriac, L.; Bonneterre, J.; Delva, R.; Ferrero, J.M.; Trillet-Lenoir, V.; Batista, G.; Viens, P.; Eymard, J.C.; Welter, S.; Rumilly, F.; Mousseau, M.; Orfeuvre, H.; Feuillade, F.; Tubiana-Matthieu, M.; Dreyfus, B.; Audhuy, B.; Pierpoint, B.; Misset, J.L.; Leduc, B. 2008: High-dose chemotherapy for patients with high-risk breast cancer: a clinical and economic assessment using a quality-adjusted survival analysis. American Journal of Clinical Oncology 31(2): 117-124

Motzer, R.J.; Bosl, G.J. 1992: High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions. Journal of the National Cancer Institute 84(22): 1703-1709

Siegert, W.; Rick, O.; Beyer, J. 1998: High-dose chemotherapy for salvage treatment of germ cell tumors Charite, Virchow Klinkum, Berlin. Bone Marrow Transplantation 22(Suppl 4): S7-S9

Cagnoni, P.J.; Shpall, E.J. 1997: High-dose chemotherapy for the treatment of breast and ovarian cancer. Current Opinion in Oncology 9(2): 122-125

Frappaz, D.; Philip, T. 1997: High-dose chemotherapy in advanced neuroblastoma. Raghavan, D Author, Leibel, S A Author, Scher, H I Author, Lange, P Author Principles and practice of genitourinary oncology : 1095-1099

Rosti, G.; Albertazzi, L.; Marangolo, M.; Gratwohl, A.; Philip, T. 1994: High-dose chemotherapy in breast cancer around Europe in 1994. Bone Marrow Transplantation 14(Suppl 1): S26-S27

Corradini, P.; Astolfi, M.; Voena, C.; Ladetto, M.; Tarella, C.; Boccadoro, M.; Pileri, A. 1996: High-dose chemotherapy in multiple myeloma Analysis of minimal Residual disease after autologous or allogeneic blood cell transplantation. British Journal of Haematology 93(Suppl 2): 251

Corradini, P.; Astolfi, M.; Ladetto, M.; Campana, S.; Comoglio, F.; Tarella, C.; Boccadoro, M.; Pileri, A. 1995: High-dose chemotherapy in multiple myeloma Residual tumor cells are detectable in PBPC and BM cell harvests and after single or double autografting. Blood 86(10 Suppl 1): 206A

Kanz, L.; Brugger, W. 1998: High-dose chemotherapy in patients with small-cell lung cancer. Annals of Hematology 77(Suppl 2): S169

Beyer, J.; Bokemeyer, C.; Rick, O.; Metzner, B.; Casper, J.; Wandt, H.; Hartmann, F.; Schmoll, H.J.; Derigs, G.; Kanz, L.; Huhn, D.; Siegert, W. 1998: High-dose chemotherapy in refractory or relapsed germ cell tumors Results from sequential trials. Bone Marrow Transplantation 22(Suppl 3): S43-S44

Tomeczko, J.; Pacuszko, T.; Klimczak, A.; Lange, A. 1998: High-dose chemotherapy in small cell lung cancer Results and factors affecting the outcome of the procedure. Bone Marrow Transplantation 22(Suppl 3): S108-S110

Droz, J.P.; Biron, P. 1995: High-dose chemotherapy in tumours other than lymphomas and breast cancer. European Journal of Cancer 31a (5): 811-812

Crown, J.; Raptis, G.; Hamilton, N.; Fennelly, D.; Vahdat, L.; Norton, L. 1995: High-dose chemotherapy of breast cancer: current status and developmental strategies. European Journal of Cancer 31a (5): 809-811

Prentice, H.G.; Lowdell, M.W.; Macdonald, I.; Herbert, L.; Wilson, H.; Black, C. 1997: High-dose chemotherapy plus T cell depleted autologous stem cell transplantation for the treatment of systemic sclerosis. British Journal of Haematology 97(Suppl 1): 39

Van der Wall, E.; Beijnen, J.H.; Rodenhuis, S. 1995: High-dose chemotherapy regimens for solid tumors. Cancer Treatment Reviews 21(2): 105-132

Rosti, G.; Albertazzi, L.; Lasset, C.; Chauvin, F.; Abdelbost, Z.; Marangolo, M.; Philip, T. 1994: High-dose chemotherapy with ABMT/PBSCT in breast cancer in Europe in 1993 What is going on?. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 137

Cagnoni, P.J.; Shpall, E.J.; Bearman, S.I.; Ross, M.; Jones, R.B. 1996: High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results. Bone Marrow Transplantation 18 Suppl. 1: S26-S29

D'hondt, L.; Andre, M.; D'hondt, V.; Doyen, C.; Canon, J.L.; Beauduin, M.; Guillaume, T.; Humblet, Y.; Bosly, A. 1994: High-dose chemotherapy with CSFs primed peripheral blood hematopoietic stem cells support in advanced solid tumors The UCL Oncology Group experience. British Journal of Haematology 87(Suppl 1): 29

Freund, M.; Andres, J.; Arseniev, L.; Kahrs, M.; Schoeffski, P.; Knoche, M.; Heussner, P.; Koenneke, A.; Schmoll, H.J.; Link, H. 1993: High-dose chemotherapy with G-CSF and peripheral stem cell support in relapsing or refractory high-grade malignant non-Hodgkins lymphomas. Annals of Hematology 67(Suppl ): A34

Voso, M.T.; Murea, S.; Goldschmidt, H.; Hohaus, S.; Haas, R. 1996: High-dose chemotherapy with PBSC support results in a significant reduction of the hematopoietic progenitor cell compartment. Annals of Hematology 73(Suppl 2): A41

Dunkel, I.J.; Finlay, J.L. 1994: High-dose chemotherapy with autologous bone marrow rescue for high-grade astrocytomas. Bone Marrow Transplantation 14(Suppl 1): S64

Bouffet, E.; Gentet, J.C.; Kalifa, C.; Mottolese, C.; Choux, M.; Hirsch, J.F.; Lasset, C.; Chauvin, F.; Philip, T. 1993: High-dose chemotherapy with autologous bone marrow rescue for medulloblastoma An European Bone Marrow Transplantation Report. Pediatric Neurosurgery 19(6): 311

Finlay, J.L.; Lindsley, K.; Garvin, J.; Walker, R.W.; Jackaki, R.; Allen, J.; Rosenblum, M.; Wisoff, J.; Epstein, F. 1993: High-dose chemotherapy with autologous bone marrow rescue in patients with recurrent or high-risk newly diagnosed medulloblastoma/primitive neuro-ectodermal tumors. Pediatric Neurosurgery 19(6): 311

Shpall, E.J.; Stemmer, S.M.; Bearman, S.I.; BastRobert, C.Jr.; Peters, W.P.; Ross, M.; Jones, R.B. 1993: High-dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer. Markman, M, Hoskins, W J Cancer of the ovary: 327-338

Extra, J.M.; Cure, H.; Viens, P.; Maraninchi, D.; Legros, M.; Marty, M. 1993: High-dose chemotherapy with autologous bone marrow transplantation for epithelial ovarian cancer. Bulletin du Cancer (Paris) 80(2): 156-162

Murakami, M.; Shinozuka, T.; Kuroshima, Y.; Tokuda, Y.; Tajima, T. 1994: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of malignant ovarian tumors. Seminars in Oncology 21(1 Suppl 1: 29-32

Fine, H.A.; Antman, K.H. 1992: High-dose chemotherapy with autologous bone marrow transplantation in the treatment of high grade astrocytomas in adults: therapeutic rationale and clinical experience. Bone Marrow Transplantation 10(4): 315-321

Bearman, S.I.; Shpall, E.J.; Jones, R.B.; Cagnoni, P.J.; Ross, M. 1996: High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer. Seminars in Oncology 23(1 Suppl 2: 60-67

Meisenberg, B.; Mcmillan, R.; Miller, W.; Piro, L. 1994: High-dose chemotherapy with autologous peripheral blood progenitor cells in the outpatient clinic. Blood 84(10 Suppl 1): 203A

Freund, M.; Andres, J.; Arseniev, L.; Link, H.; Kahrs, M.; Schoeffski, P.; Knoche, M.; Heussner, P.; Poliwoda, H. 1994: High-dose chemotherapy with autologous peripheral blood stem cell reinfusion Alternative to autologous BMT?. Journal of Cancer Research and Clinical Oncology 120(Suppl ): R127

Rahman, Z.U.; Hortobagyi, G.N.; Buzdar, A.U.; Champlin, R. 1998: High-dose chemotherapy with autologous stem cell support in patients with breast cancer. Cancer Treatment Reviews 24(4): 249-263

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J.; Bearman, S.I.; Ross, M.; Sedlacek, S.M.; Jones, R.B. 1997: High-dose chemotherapy with autologous stem cell transplant for inflammatory breast cancer. Breast Cancer Research and Treatment 46(1): 72

Reinhold, U.; Frick, M.; Fischer, J.; Schupp, G.; Kreysel, H.W. 1996: High-dose chemotherapy with autologous stem cell transplantation in a patient with a CD30+ anaplastic large cell lymphoma of the skin. British Journal of Dermatology 134(4): 811-813

Gill, P.; Litzow, M.; Buckner, J.; Arndt, C.; Moynihan, T.; Christianson, T.; Ansell, S.; Galanis, E. 2008: High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer 112(8): 1805-1811

Frickhofen, N. 1998: High-dose chemotherapy with hematopoietic progenitor cell support for treatment of patients with advanced ovarian cancer. Annals of Hematology 77(Suppl 2): S12

Cure, H.; Extra, J.M.; Viens, P.; Lotz, J.P.; Guastalla, J.P.; Dieras, V.; Legros, M.; Maraninchi, D.; Izrael, V.; Pouillart, P.; Marty, M.; Plagne, R. 1998: High-dose chemotherapy with hematopoietic stem cell support as consolidation therapy for patients with platinum-sensitive advanced epithelial ovarian cancer. Bone Marrow Transplantation 22(Suppl 3): S102-S104

Nishiyama, T.; Kishi, K.; Deguchi, T.; Mukaiyama, T.; Terunuma, M. 1996: High-dose chemotherapy with peripheral blood stem cell transplantation for hormone-refractory advanced carcinoma of the prostate preliminary results. Journal of Urology 155(5 Suppl): 576A

Frakes, L.; Miller, W.; Mcmillan, R.; Meisenberg, B. 1996: High-dose chemotherapy with peripheral blood stem cell transplantation for mantle cell lymphoma. Blood 88(10 Suppl 1 Part 1-2): 283B

Reed, E.; Vaughan, W.; Schmidt Pokorny, K.; Edwards, B.; Kessinger, A. 1992: High-dose chemotherapy with peripheral stem cell rescue in patients with metastatic breast cancer. Breast Cancer Research and Treatment 23(1-2): 134

Frei, E.IIi; Bitran, J.; Ayash, L.; Elias, A.; Griswald, D.; Teicher, B.; Richardson, P.; Wheeler, C. 1997: High-dose chemotherapy with stem cell protection Tandem, sequence, and phenylalanine mustard studies. Salmon, S E Adjuvant Therapy of Cancer 111-115

Ohlsson, H.; Lykkesfeldt, A.E.; Madsen, M.W.; Briand, P. 1998: High-dose chemotherapy with stem cell support in breast cancer. Anticancer Research 18(5C): 3868-3869

Tokmak, F.; Quack, I.; Schieren, G.; Sellin, L.; Rattensperger, D.; Holland-Letz, T.; Weiner, S.M.; Rump, L.C. 2008: High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 23(12): 4016-4020

Mccarty, M.F. 1998: High-dose chromium/biotin treatment of type II diabetes. Official Gazette of the United States Patent and Trademark Office Patents 1213(1): 610

Rossi, S.J.; Healy, D.P.; Savani, D.V.; Deepe, G. 1993: High-dose ciprofloxacin in the treatment of a renal cyst infection. Annals of PharmacoTherapy 27(1): 38-39

Schiller, J.H. 1996: High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer. Seminars in Oncology 23(4 Suppl 8: 78-82

Lyttelton, M.P.A.; Newlands, E.S.; Giles, C.; Bower, M.; O'reilly, S.; Rustin, G.J.S.; Samson, D.M.; Kanfer, E.J. 1997: High-dose combination chemotherapy including carboplatin adjusted for renal function in patients with relapsed and refractory germ cell tumour. British Journal of Haematology 97(Suppl 1): 41

Elias, A.D.; Ayash, L.; Skarin, A.T.; Wheeler, C.; Schwartz, G.; Mazanet, R.; Tepler, I.; Schnipper, L.; Frei, E.; Antman, K.H. 1993: High-dose combined alkylating agent therapy with autologous stem cell support and chest radiotherapy for limited small-cell lung cancer. Chest 103(4 Suppl): 433s-435s

Lebesque, J.V.; Bruce, A.; Boersma, L.J.; Te Velde, A. 1996: High-dose conformal radiotherapy for prostate cancer The relation between observed late bladder and rectum complications and parameters derived from the dose volume histograms. International Journal of Radiation Oncology Biology Physics 36(1 Suppl): 246

Ladenstein, R.; Lasset, C.; Hartmann, O.; Garaventa, A.; Philip, T. 1993: High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma. European Journal of Cancer 29A(11): 1632

Droz, J.P.; Kattan, J.; Bonnay, M.; Chraibi, Y.; Bekradda, M.; Culine, S. 1993: High-dose continuous-infusion fosfestrol in hormone-resistant prostate cancer. Cancer 71(3 Suppl): 1123-1130

Trobe, J.D. 1994: High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Archives of Ophthalmology 112(1): 35-36

Gluck, S.; Cano, P.; Dorreen, M.; Germond, C.; Lopez, P.; Arnold, A.; Dulude, H.; Gallant, G. 1996: High-dose cyclophosphamide , mitoxantrone , and paclitaxel for the treatment of metastatic breast cancer with stem cell support. Breast Cancer Research and Treatment 41(3): 277

Reed, E.C.; Tarantolo, S.R.; Edwards, B.; Kessinger, M.A. 1994: High-dose cyclophosphamide and thiotepa for treatment of high-risk breast cancer. Breast Cancer Research and Treatment 32(Suppl ): 66

Perry, J.; Case, D.; Shipley, D.; Melisko, M.; Cruz, J.M.; Radford, J.; Greven, K.; Hurd, D. 1996: High-dose cyclophosphamide and total body irradiation with autologous hematopoietic cell transplantation for poor-prognosis non-Hodgkins Lymphoma Outcome analysis by histologic grade and disease status at transplant. Blood 88(10 Suppl 1 Part 1-2): 119A

Tringali, S.; Santoro, A.; Majolino, I.; Barbata, G.; Gentile, S.; Vasta, S.; Scime, R.; Indovina, A.; Pampinella, M.; Caronia, F. 1993: High-dose cyclophosphamide for mobilization of circulating stem cells in chronic myeloid leukemia. Stem Cells 11(Suppl 3): 136

Brodsky, R.A.; Smith, B.D.; Chen, A.; Doeblin, T.D.; Dorr, D.; Brodsky, I.; Jones, R.J. 1997: High-dose cyclophosphamide without bone marrow transplant for newly diagnosed or refractory severe aplastic anemia. Blood 90(10 Suppl 1 Pt 1): 440A

Brodsky, R.A.; Smith, B.D.; Brodsky, I.; Anhalt, G.; Petri, M.; Jones, R.J. 1997: High-dose cyclophosphamide without bone marrow transplant for refractory severe autoimmune diseases. Blood 90(10 Suppl 1 Pt 1): 234A

Gonzalez Llano, O.; Jaime Perez, J.C.; Herrera Garza, J.L.; Gomez Almaguer, D. 1998: High-dose cyclophosphamide without bone marrow transplant in the treatment of children with severe aplastic anemia. Blood 92(10 Suppl 1 Part 1-2): 16B

Tehlirian, C.V.; Hummers, L.K.; White, B.; Brodsky, R.A.; Wigley, F.M. 2008: High-dose cyclophosphamide without stem cell rescue in scleroderma. Annals of the Rheumatic Diseases 67(6): 775-781

Lahuerta Palacios, J.J.; Grande, C.; De La Serna, J.; Bargay, J.; Bornstein, R.; Ortiz, M.C.; Toscano, R.; Larregla, S. 1996: High-dose cyclophosphamide, BCNU and VP-16 supported with a second autologous hemopoietic transplant in multiple myeloma chemosensitive to melfalan 200 mg/m-2 First interim report. British Journal of Haematology 93(Suppl 2): 83

Lahuerta Palacios, J.J.; Grande, C.; De La Serna, J.; Bornstein, R.; Bargay, J.; Conde, E.; Toscano, R.; Oritz, M.C.; Gonzalez San Miguel, J.D.; Albo, C.; Larregla, S.; Ayala, R.; Besalduch, J.; Iriondo, A. 1997: High-dose cyclophosphamide, BCNU and VP-16 supported with second autologous hemopoietic transplant in multiple myeloma chemosensitive to melphalan 200 mg/m2 An interim report. Blood 90(10 Suppl 1 Pt 1): 232A

Reece, D.; Spinelli, J.; Barnett, M.; Connors, J.; Hogge, D.; Klingemann, H.; Fairey, R.; Klasa, R.; Nantel, S.; O'reilly, S.; Shepherd, J.; Voss, N.; Sutherland, H.; Phillips, G. 1994: High-dose cyclophosphamide, BCNU, VP16-213 +- cisplatin and autologous stem cell transplantation for patients with Hodgkins disease who fail to enter a complete remission after combination chemotherapy. Blood 84(10 Suppl 1): 162A

Reese, D. 1995: High-dose cyclophosphamide, BCNU, etoposide racemic cisplatin followed by autologous bone marrow transplantation for Hodgkins disease. Bone Marrow Transplantation 15(Suppl 1): S208-S210

Goldberg, S.L.; Klumpp, T.R.; Mangan, K.F.; Macdonald, J.S. 1994: High-dose cyclophosphamide, etoposide, and carboplatin followed by autologous bone marrow and/or stem cell support for high-risk breast cancer. Journal of Cellular Biochemistry Suppl 1994(18B): 95

Antman, K.; Ayash, L.; Elias, A.; Wheeler, C.; Schwartz, G.; Mazanet, R.; Tepler, I.; Schnipper, L.E.; Frei, E. 1994: High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age. Journal of the National Cancer Institute. Monographs 16: 91-94

Krueger, W.H.; Kroeger, N.; Schaefer Eckert, K.; Wandt, H.; Gieseking, F.; Jonat, W.; Zander, A.R. 1997: High-dose cyclophosphamide/thiotepa/mitoxantrone with peripheral blood stem cell support for inflammatory breast cancer-preliminary results. Breast Cancer Research and Treatment 46(1): 73

Cherqui, D.; Duvoux, C.; Salvat, A.; Lauzet, J.Y.; Metreau, J.M.; Julien, M.; Fagniez, P.L.; Dhumeaux, D. 1995: High-dose cyclosporine a induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study. Transplantation Proceedings 27(1): 1134-1135

Kulkarni, S.; Powles, R.; Eisen, T.; Treleaven, J.; Singhal, S.; Middleton, G.; Horton, C.; Mehta, J. 1996: High-dose cytarabine and VP-16 with or without idarubicin for relapsed acute leukemia. Blood 88(10 Suppl 1 Part 1-2): 174B

Tarantolo, S.R.; Bishop, M.R.; Pavletic, Z.S.; Sanger, W.G.; Warkentin, P.I.; Zacharias, D.; Armitage, J.O.; Kessinger, A. 1997: High-dose cytarabine and allogenic blood stem cell transplant for relapsed leukemia. Blood 90(10 Suppl 1 Pt 1): 227A

Heil, G.; Freund, M.; Link, H.; Mitrou, P.; Hoelzer, D.; Wandt, H.; Ehninger, G.; Fackler Schwalbe, E.; Schlimok, G. 1992: High-dose cytarabine and daunorubicin postremission chemotherapy for the treatment of adults with de novo acute myelogenous leukemia. Annals of Hematology 65(Suppl ): A66

Mehta, J.; Powles, R.; Treleaven, J.; Kulkarni, S.; Swansbury, G.J.; Hamblin, M.; Saso, R.; Killick, S.; Rege, K.; Singhal, S. 1997: High-dose cytarabine and etoposide for induction of remission in acute myeloid leukemia The effect of additional idarubicin. Blood 90(10 Suppl 1 Pt 1): 507A

Baer, M.R.; Pixley, L.A.; Lawrence, D.; O'loughlin, K.L.; Abdel Razeq, S.; Block, A.W.; Sait, S.N.J.; Wetzler, M.; Christiansen, N.P.; Frankel, S.R.; Herzig, G.P.; Bloomfield, C.D. 1998: High-dose cytarabine and idarubicin is effective remission induction therapy for older de novo but not for secondary acute myeloid leukemia patients. Blood 92(10 Suppl 1 Part 1-2): 231A

Vaughn, D.J.; Jarvik, J.G.; Hackney, D.; Peters, S.; Stadtmauer, E.A. 1993: High-dose cytarabine neurotoxicity: MR findings during the acute phase. Ajnr. American Journal of Neuroradiology 14(4): 1014-1016

Hansz, J.; Gozdzik, J.; Drozdowska, D.; Czyz, A. 1998: High-dose cytarabine to intensify the Dexa-BEAM conditioning regimen followed by autografting for poor-prognosis Hodgkins disease. Blood 92(10 Suppl 1 Part 1-2): 365B

Baer, M.R.; Christiansen, N.P.; Frankel, S.R.; Brunetto, V.L.; Mrózek, K.; Bloomfield, C.D.; Herzig, G.P. 1993: High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia. Seminars in Oncology 20(6 Suppl 8: 6-12

Brown, R.A.; Wolff, S.; Fay, J.; Pineiro, L.; Greer, J.; Lynch, J.; Collins, R.; Stevens, D.; Herzig, R.; Herzig, G.P. 1994: High-dose cytosine arabinoside /daunorubicin induction followed by high-dose etoposide /cyclophosphamide consolidation for patients with AML. Blood 84(10 Suppl 1): 146A

Heil, G.; Mitrou, P.S.; Hoelzer, D.; Freund, M.; Link, H.; Ehninger, G.; Steinke, B.; Oehl, S.; Wandt, H.; Fackler Schwalbe, E.; Schlimok, G.; Loesch, A.; Queisser, W.; Loeffler, B.; Gaus, W.; Hoegel, J.; Heimpel, H.; Kurrle, E. 1995: High-dose cytosine arabinoside and daunorubicin postremission therapy in adult de-novo AML patients Long-term results of a prospective multicenter trial. Annals of Hematology 70(Suppl 2): A134

Wolff, S.N.; Brown, R.A.; Fay, J.W.; Herzig, G.P.; Herzig, R.H.; Phillips, G.L. 1992: High-dose cytosine arabinoside for the treatment of acute myeloid leukemia. Leukemia 6(Suppl 4): 71-74

Cole, N.; Gibson, B.E. 1997: High-dose cytosine arabinoside in the treatment of acute myeloid leukaemia. Blood Reviews 11(1): 39-45

Burk, M.; Volmer, M.; Kliche, K.O.; Wehmeier, A.; Schneider, W. 1992: High-dose cytosine-arabinoside in acute leukemia Pharmacokinetic evaluation. Annals of Hematology 65(Suppl ): A42

Santini, G.; Congiu, A.M.; Figari, O.; Debernardis, D.; Canepa, L.; Miglino, M.; Palmisano, G.L.; Nati, S.; Pierluigi, D.; Damasio, E. 1994: High-dose cytoxan + G-CSF primed peripheral progenitor cells and autograft for non-Hodgkins lymphoma with persistent bone marrow involvement. Experimental Hematology 22(8): 776

Borst, F.; Keuning, J.J.; Sinnige, H.A.M.; Van Hulsteijn, L.H.; Vreugdenhil, G. 1998: High-dose dexamethasone as a treatment of idiopathic thrombocytopenic purpura. British Journal of Haematology 102(1): 364

Bulvik, S.; Winder, A.; Ben-Tal, O.; Szold, A.; Eldor, A. 1998: High-dose dexamethasone for splenectomy in patients with idiopathic thrombocytopenic purpura. Haemostasis 28(5): 256-259

Schiavotto, C.; Ruggeri, M.; Castaman, G.; Rodeghiero, F. 1996: High-dose dexamethasone in refractory idiopathic thrombocytopenic purpura. British Journal of Haematology 93(Suppl 2): 185

Wilson, G.E.; Jones, B.; Douglas, L.; Hind, C.R.K.; Littler, J. 1996: High-dose endobronchial radiotherapy for lung cancer Can we predict which symptoms will be palliated?. European Respiratory Journal Suppl 9(23): 96S

Wilson, G.E.; Jones, B.; Douglas, L.; Hind, C.R.K.; Littler, J. 1996: High-dose endobronchial radiotherapy for lung cancer Does performance status predict benefit?. European Respiratory Journal Suppl. 9(23): 10s

Kirkeby, A.; Torup, L.; Bochsen, L.; Kjalke, M.; Abel, K.; Theilgaard-Monch, K.; Johansson, P.är.I.; Bjørn, S.ør.E.; Gerwien, J.; Leist, M. 2008: High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thrombosis and Haemostasis 99(4): 720-728

Kuhlmann, B.V.; Vogt, A.; Beer, J.H.; Mullis, P.E. 1998: High-dose estrogen therapy in tall girls How to find patients at risk for thromboembolic complications?. Hormone Research (Basel) 50(Suppl 3): 31

Blume, K.G.; Forman, S.J. 1992: High-dose etoposide -containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies. Seminars in Oncology 19(6 Suppl 13): 63-66

Pineiro, L.; Fay, I.; Collins, R.; Brown, R.; Herzig, R.; Wolff, S.; Phillips, G.; Herzig, G. 1993: High-dose etoposide, cyclophosphamide, total body irradiation and allogeneic bone marrow transplant for patients with chronic myeloid leukemia Results from the North American Transplant Group. Blood 82(10 Suppl 1): 169A

Brown, R.A.; Wolff, S.; Fay, J.; Pineiro, L.; Green, J.; Lynch, J.; Collins, R.; Stevens, D.; Herzig, R.; Herzig, G.P. 1993: High-dose etoposide, cyclophosphamide, total body irradiation and allogeneic bone marrow transplant for patients with resistant acute myeloid leukemia A phase I-II trial by the North American marrow transplant. Blood 82(10 Suppl 1): 166A

Fetscher, S.; Lange, W. 1998: High-dose etoposide, ifosfamide, cis/carboplatin and epirubicin in advanced soft tissue sarcomas. Bone Marrow Transplantation 22(Suppl 3): S78-S81

Brochstein, J.A.; Pecora, A.L.; Van Vliet, A. 1993: High-dose etoposide, thiotepa and cyclophosphamide with autologous marrow support for pediatric patients with high-risk solid tumors. Blood 82(10 Suppl 1): 628A

Dyer, M.A.; Freudenreich, O.; Culhane, M.A.; Pachas, G.N.; Deckersbach, T.; Murphy, E.; Goff, D.C.; Evins, A.E. 2008: High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia. Schizophrenia Research 102(1-3): 88-95

Hatcher, H.C.; Grant, M.B.; Caballero, S.; Crouch, R.K.; Ma, J.X. 1996: High-dose glucose induced apoptosis in human retinal vascular endothelial cells. IOVS Investigative Ophthalmology and Visual Science 37(3): S797

De Zegher, F.; Maes, M.; Heinrichs, C.; Thiry, G.; Du Caju, M.V.L.; De Schepper, J.; Craen, M.; Chanoine, J.P.; Dooms, L.; Malvaux, P. 1994: High-dose growth hormone therapy for short children born small for gestational age. Acta Paediatrica Suppl 1994(399): 77

Fuhrman, G.M.; Hohn, D.C.; Curley, S.A. 1992: High-dose hepatic arterial adriamycin with systemic protection provided by a novel hepatic venous isolation catheter and extracorporeal chemofiltration. Surgical Forum 43: 440-442

Killeen, A.A.; Ramey, M.L.; Dean, J.J. 1993: High-dose hook effect in an immunoluminometric thyrotropin assay: the open-faced sandwich artefact. Annals of Clinical Biochemistry 30: 413-414

Treleaven, J.; Powles, R.; Singhal, S.; Swansbury, G.J.; Millar, B.; Shepherd, V.; Bell, J.; Min, T.; Cabral, S.; Mehta, J. 1995: High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia. Blood 86(10 Suppl 1): 405A

Hardan, I.; Brok Simoni, F.; Rosenthal, E.; Trakhtenbrot, L.; Raz, H.; Sareli, R.; Rosner, E.; Berkowicz, M.; Ben Bassat, I. 1996: High-dose hydroxyurea and GCSF for the preparation of a Philadelphia negative autologous stem cell graft in newly diagnosed patients with chronic myeloid leukemia. Blood 88(10 Suppl 1 Part 1-2): 256A

Petti, M.C.; Spiriti, M.A.A.oe; Montefusco, E.; Redi, R.; Mancini, M.; Comandini, A.; D'elia, G.M.; Mandelli, F. 1998: High-dose hydroxyurea in the treatment of poor risk acute myeloid leukemia. British Journal of Haematology 102(1): 222

Huenerlituerkoglu, A.; Kobbe, G.; Bauser, U.; Schneider, P.; Meckenstock, G.; Niederste Hollenberg, A.; Aul, C.; Heyll, A. 1998: High-dose idarubicin added to CBV as an intensified high-dose-chemotherapy protocol for patients with primary refractory or relapsed malignant lymphoma. Annals of Hematology 77(Suppl 2): S192

Reichardt, P.; Tilgner, J.; Sachs, U.; Pecher, G.; Doerken, B. 1996: High-dose ifosfamide in heavily pretreated patients with bone and soft tissue sarcoma. Annals of Hematology 73(Suppl 2): A100

Demetri, G.D. 1996: High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone. Seminars in Oncology 23(3 Suppl 6: 22-26

Fields, K.K.; Elfenbein, G.J.; Perkins, J.B.; Janssen, W.E.; Ballester, O.F.; Hiemenz, J.W.; Zorsky, P.E.; Kronish, L.E.; Foody, M.C. 1994: High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion. Seminars in Oncology 21(5 Suppl. 12): 86-92

Elias, A.D.; Ayash, L.J.; Wheeler, C.; Schwartz, G.; Tepler, I.; McCauley, M.; Mazanet, R.; Schnipper, L.; Frei, E.; Antman, K.H. 1994: High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions. Seminars in Oncology 21(5 Suppl 12: 83-85

Piette, J.C.; Frances, C.; Roy, S.; Papo, T.; Godeau, P. 1995: High-dose immuno-globulins in the treatment of refractory cutaneous lupus erythematosus Open trial in 5 cases. Arthritis and Rheumatism 38(9 Suppl): S304

Voit, T. 1993: High-dose immunoglobulin therapy of childhood epilepsy. Infusionstherapie und Transfusionmedizin 20(Suppl 1): 146-148

Rübo, J.; Wahn, V. 1993: High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility. Infusionstherapie und Transfusionsmedizin 20(Suppl 1): 104-108; Discussion 109

Horneff, G.; Schwab, J.; Holtz, N.; Kalden, J.R.; Burmester, G.R. 1993: High-dose immunoglobulin therapy of rheumatoid arthritis. Infusionstherapie und Transfusionsmedizin 20(Suppl 1): 110-115; Discussion: 116-117

Mcsweeney, P.A.; Furst, D.E.; Storek, J.; Nash, R.A.; Nelson, J.L.; Wener, M.; Sullivan, K.M. 1998: High-dose immunosuppressive therapy using total body irradiation , cyclophosphamide and ATG with autologous CD34-selected peripheral blood stem cell rescue as treatment for severe systemic sclerosis. Blood 92(10 Suppl 1 Part 1-2): 295A

Flamm, S.; Conjeevarum, H.; Wiley, T.; Ganger, D.; O'riordan, K. 1998: High-dose induction vs standard dosage interferon alpha in naive hepatitis C patients Preliminary analysis of a multicenter, randomized, controlled trial. Hepatology 28(4 Part 2): 282A

Ganger, C.D.; Conjeevaram, H.; Wiley, T.; Flamm, S.; O'riordan, K. 1998: High-dose induction with interferon alpha 2b is safe and efficacious in interferon relapsers and non-responders with chronic hepatitis C. Gastroenterology 114(4 Part 2): A1244

Caron, P.C.; Jurcic, J.G.; Dumont, L.; Tyson, D.; Scheinberg, D.A. 1996: High-dose infusional humanized anti-CD33 M195 Prospects for treating minimal disease in myeloid leukemia. Blood 88(10 Suppl 1 Part 1-2): 218A

Viens, P.; Nouyrigat, P.; Baume, D.; Camerlo, J.; Resbeut, M.; Novakovitch, G.; Mannoni, P.; Maraninchi, D. 1994: High-dose intensity polychemotherapy with peripheral blood stem cell support as out-patient treatment in poor prognosis breast cancer. Bone Marrow Transplantation 14(Suppl 1): S32

Van Vlierberghe, H.; Elewaut, A.E.; Leroux Roels, G.; Elewaut, A. 1997: High-dose interferon alfa 2B retreatment in hepatitis C positive non 1B non-responders results in a high percentage of sustained response. Journal of Hepatology 26(Suppl 1): 193

Wietzke, P.; Stuckenberger, D.; Ramadori, G. 1998: High-dose interferon-alpha 2a therapy for acute viral hepatitis C infection. Hepatology 28(4 Part 2): 696A

Klapper, J.A.; Downey, S.G.; Smith, F.O.; Yang, J.C.; Hughes, M.S.; Kammula, U.S.; Sherry, R.M.; Royal, R.E.; Steinberg, S.M.; Rosenberg, S. 2008: High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006. Cancer 113(2): 293-301

Parkinson, D.R.; Sznol, M. 1995: High-dose interleukin-2 in the therapy of metastatic renal-cell carcinoma. Seminars in Oncology 22(1): 61-66

Younes, A.; Jendiroba, D.; Hu, Y.; Rodriguez, M.A.; Stary, S.; Cabanillas, F.; Andreeff, M. 1994: High-dose interleukin-3 increases circulating natural killer cells and decreases CD19+ cells in patients with follicular small-cleaved cell lymphoma. Experimental Hematology 22(8): 836

Fizazi, K.; Asselain, B.; Jouve, M.; Palangie, T.; Dieras, V.; Beuzeboc, P.; Dorval, T.; Garcia Giralt, E.; Pouillart, P. 1994: High-dose intra-thecal methotrexate with leucovorin rescue for meningeal carcinomatosis in breast cancer. Breast Cancer Research and Treatment 32(Suppl ): 34

Muti, G.; De Gasperi, A.; Nosari, A.M.; Caimi, M.T.; Saladini, A.; Mazza, E.; Baudo, F.; Morra, E. 1996: High-dose intravenous gamma globulin for severe thrombocytopenia after liver transplantation. Blood 88(10 Suppl 1 Part 1-2): 61B

Oliet, A.; Hernández, E.; Gallar, P.; Vigil, A. 1992: High-dose intravenous gamma-globulin in systemic lupus erythematosus. Nephron 62(4): 465

Esteves, F.P.; Braga, J.C.; Latado, A.; AzevedoA.Jr.; Brito, J.C.; Sousa, A.J.N.ri; Rocha, M.S.; RabeloAlvaro, J.; Esteves, J.P.ricles 1996: High-dose intravenous heparin as an alternative to thrombolytics in the treatment of patients with acute myocardial infarction The HAPI study. European Heart Journal 17(ABSTR Suppl ): 122

Kondo, H.; Imamura, T. 1998: High-dose intravenous immune globulin and the response to splenectomy monitoring with platelet-associated IgG in patients with idiopathic thrombocytopenic purpura. European Journal of Haematology 61(3): 213-215

Okubo, S.; Nomura, S.; Yasunaga, K.; Takayama, H.; Okuma, M.; Fujimura, K.; Kuramoto, A.; Fujisawa, K.; Akatsuka, J. 1993: High-dose intravenous immune globulin therapy for idiopathic thrombocytopenic purpura-efficacy and safety related of anti-red blood cell antibody levels contained in immune globulin products. Japanese Archives of Internal Medicine 40(7): 195-208

Roifman, C.M. 1993: High-dose intravenous immune serum globulin replacement in hypogammaglobulinemia Optimal replacement and individualization of dosing regimens. Spirer, Z , Roifman, C M , Branski, D Pediatric and Adolescent Medicine; Pediatric immunology : 197-209

Monova, D.V.; Belovezhdov, N.I. 1993: High-dose intravenous immunoglobulin G in the treatment of nephrotic syndrome in secondary amyloidosis complicated rheumatoid arthritis. Nephrology Dialysis Transplantation 8(9): 925

Ferrero, B.; Durelli, L. 2002: High-dose intravenous immunoglobulin G treatment of myasthenia gravis. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 23(Suppl 1): S9-24

Otheo, E.; Maldonado, M.S.; Muñoz, A.; Hernández-Jodra, M. 1997: High-dose intravenous immunoglobulin as single therapy in a child with autoimmune hemolytic anemia. Pediatric Hematology and Oncology 14(5): 487-490

Dalakas, M.C.; Sonies, B.; Koffman, B.; Spector, S.; Sivakumar, K.; Cupler, E.; Lopez Devine, J. 1997: High-dose intravenous immunoglobulin combined with prednisone in the treatment of patients with inclusion-body myositis A double blind, randomised controlled trial. Neurology 48(3 Suppl 2): A332

Van Genderen, P.J.; Terpstra, W.; Michiels, J.J.; Kapteijn, L.; van Vliet, H.H. 1995: High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease. Thrombosis and Haemostasis 73(5): 891-892

Enders, U.; Gold, R.; Toyka, K.V.; Hartung, H.P. 1996: High-dose intravenous immunoglobulin does not affect autoimmune demyelination of the peripheral nervous system. Neurology 46(2 Suppl): A286

Villa, A.M.; Allievi, A.; Sevlever, G.; Sica, R.E.P. 1997: High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy and monoclonal gammopathy. Journal of the Neurological Sciences 150(Suppl ): S107

Dalakas, M.C.; Mccrosky, S.; D'ambrosia, J.M.; Illa, I.; Soueidan, S.A.; Otero, C.; Stein, D.P.; Dinsmore, S.T.; Sonies, B.C. 1993: High-dose intravenous immunoglobulin in the treatment of dermatomyositis A double-blind placebo-controlled trial. Neurology 43(4 Suppl 2): A356-A357

Ferrero, B.; Aimo, G.; Durelli, L.; Cavallo, R.; Ferri, R.; Bongioanni, M.R.; Bergamasco, B. 1994: High-dose intravenous immunoglobulin prevents corticosteroid -induced worsening of myasthenia gravis. Neurology 44(4 Suppl 2): A290

Vrethem, M.; Lindvall, B.; Kihlstrand, S.; Backman, E.; Brismar, T.; Fredman, P.; Henriksson, K.G. 1994: High-dose intravenous immunoglobulin therapy improved muscle strength in two patients with multifocal motor neuropathy. Journal of Neuroimmunology 54(1-2): 204

Knutsen, A.P.; Fenton, G. 1998: High-dose intravenous immunoglobulin therapy in three children with seizure disorders and autistic features. Pediatric Asthma Allergy and Immunology 12(3): 213-216

Bodenstein, H. 1993: High-dose intravenous immunoglobulin therapy of aplastic anemia. Infusionstherapie und Transfusionmedizin 20(Suppl 1): 99-102

Gangarossa, S.; Lucini, N.R. 1993: High-dose intravenous immunoglobulin therapy, blood rheology, and sickle cell anemia. Pediatric Hematology and Oncology 10(4): 377-378

Rosti, L. 1996: High-dose intravenous immunoglobulins. Journal of Perinatal Medicine 24(5): 539

Schiavotto, C.; Ruggeri, M.; Castaman, G.; Rodeghiero, F. 1998: High-dose intravenous immunoglobulins Adverse reactions in 125 patients with ITP. British Journal of Haematology 102(1): 363

Messer, G.; Sizmann, N.; Feucht, H.; Meurer, M. 1995: High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris. British Journal of Dermatology 133(6): 1014-1016

Zeuner, R.A.; Beress, R.; Euler, H.H.; Schroeder, J.O. 1997: High-dose intravenous immunoglobulins induce a reduction of complement mediated inhibition of immune precipitation and of complement C4 levels. Arthritis and Rheumatism 40(9 Suppl): S85

Eisfelder, B.; Ziegler, A.G.; Standl, E.; Schnell, O. 1996: High-dose intravenous insulin infusion in newly-diagnosed IDDM Effects on beta-cell function. Diabetologia 39(Suppl 1): A52

Zacharof, A.K.; Petrogiannopoulos, C.; Flevaris, C.; Poulikakos, J. 1996: High-dose intravenous methylprednisolone therapy for pain in patients with sickle beta-thalassemia. British Journal of Haematology 93(Suppl 2): 35

Kim, S.Y.; Marmor, M.F. 1994: High-dose intravitreal dextromethorphan reversibly suppresses the ERG. IOVS Investigative Ophthalmology and Visual Science 35(4): 1868

Ducreux, M.; Raoul, J-Luc.; Marti, P.; Merrouche, Y.; Tigaud, J-Marie.; Rebischung, C.; Boige, Vérie. 2008: High-dose irinotecan plus LV5FU2 or simplified LV5FU (HD-FOLFIRI) for patients with untreated metastatic colorectal cancer: a new way to allow resection of liver metastases?. Oncology 74(1-2): 17-24

Schroeder, J.O.; Teske, E.; Heer, A.; Euler, H.H.; Loffler, H. 1992: High-dose iv immunoglobulins in systemic lupus erythematosus Results of a pilot trial. Arthritis and Rheumatism 35(9 Suppl): S154

Ruszniewski, P.; Levy, P.; Hammel, P.; Catus, F.; Zins, M.; Bernades, P. 1996: High-dose lanreotide in the treatment of pancreatic adenocarcinomas A prospective phase II study. Gastroenterology 110(4 Suppl): A427

Faiss, S.; Scheruebl, H.; Raeth, U.; Bonath, T.; Riecken, E.O.; Wiedenmann, B. 1995: High-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumors. Gastroenterology 108(4 Suppl): A465

Tüchy, G.L.; Reckendorfer, H.; Burgmann, H.; Sperlich, M.; Steltzer, H.; Tüchy, E.; Weindlmayr-Göttel, M.; Spieckermann, P.G.; Schwarz, S. 1993: High-dose laudanosine enhances liver cell activity and bile flow during reperfusion of the liver. Transplantation Proceedings 25(2): 1855-1857

Cortes, J.; Kantarjian, H.; O'brien, S.; Giles, F.J.; Koller, C.; Beran, M.; Keating, M.; Estey, E. 1998: High-dose liposomal daunorubicin and Ara-C for refractory or relapsed acute leukemias A dose searching study. Blood 92(10 Suppl 1 Part 1-2): 234A

Davidson, N.C.; Coutie, W.J.; Struthers, A.D. 1995: High-dose lisinopril is more effective than low-dose in suppressing aldosterone in patients with chronic heart failure. Journal of the American College of Cardiology 1995(SPEC ISSUE): 177A

Davidson, N.C.; Coutie, W.J.; Struthers, A.D. 1995: High-dose lisinopril reduces blood pressure, aldosterone, creatine clearance and urinary atrial natriuretic peptide levels more than low-dose lisinopril in heart failure. European Heart Journal 16(ABSTR Suppl ): 152

Schouten, L.J.; Volovics, A.; Hupperets, P.S.G.J.; Jager, J.J.; Thunnissen, F.B.J.M.; Verbeek, A.L.M.; Blijham, G.H. 1995: High-dose medroxyprogesterone acetate and the risk of contralateral breast cancer. American Journal of Epidemiology 141(11 Suppl): S66

Ministry, O.Welfare (Japan) 1992: High-dose medroxyprogesterone acetate and thrombosis. Journal of the Japan Pharmaceutical Association 44(10): 1393-1395

Focan, C.; Beauduin, M.; Salamon, E.; De Greve, J.; De Wasch, G.; Lobelle, J.P.; Majois, F.; Tagnon, A.; Tytgat, J.; Van Belle, S.; Vandervellen, R.; Vindevoghel, A. 1995: High-dose medroxyprogesterone acetate as adjuvant hormonotherapy for early breast cancer Importance of age, menopausal and nodal status as prognostic determinants Ten years results of a multicenter randomized trial. Anticancer Research 15(5A): 1716-1717

Focan, C.; Beauduin, M.; Salamon, E.; De Greve, J.; De Wasch, G.; Lobelle, J.P.; Majois, F.; Tagnon, A.; Tytgat, J.; Van Belle, S.; Vandervellen, R.; Vindevoghel, A. 1995: High-dose medroxyprogesterone acetate as adjuvant hormonotherapy in early breast cancer 9 years results of a multicenter randomized trial. Jonat, W. , Kaufmann, M. , Munk, K. Contributions To Oncology; Hormone-Dependent Tumors: Basic Research And Clinical Studies. 145-158

Cruz, J.M.; Muss, H.B.; Russell, G. 1992: High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer. Oncology 49(Suppl 2): 8-11

Mehta, J.; Ayers, D.; Mattox, S.; Singh, J.; Singhal, S.; Siegel, D.; Fassas, A.; Desikan, K.; Vesole, D.; Munshi, N.; Anaissie, E.; Tricot, G.; Barlogie, B.; Jagannath, S. 1997: High-dose melphalan and autotransplantation in myeloma with renal impairment A matched-pair comparison with patients without renal failure. Blood 90(10 Suppl 1 Pt 1): 419A

Briggs, A.D.; Taylor, C.W.; Sturm, T.J.; Shapiro, T.W.; List, A.F. 1998: High-dose melphalan and etoposide prior to autologous hematopoietic stem cell transplant is an effective regimen in the treatment of multiple myeloma. Blood 92(10 Suppl 1 Part 1-2): 362B

Goldschmidt, H.; Hegenbart, U.; Hohaus, S.; Benner, A.; Wannenmacher, M.; Haas, R.; Ho, A.D. 1998: High-dose melphalan plus total body irradiation induces higher non-hematological toxicity without improving remission status, event free - - and overall survival compared to HD-MEL alone in patients with multiple myeloma. Blood 92(10 Suppl 1 Part 1-2): 129A

Comenzo, R.L.; Vosburgh, E.; Sarnacki, D.L.; Falk, R.; Simms, R.; Wright, D.G.; Skinner, M. 1995: High-dose melphalan with blood stem-cell support for AL amyloidosis. Blood 86(10 Suppl 1): 206A

Gertz, M.A.; Pineda, A.A.; Chen, M.G.; Letendre, L.; Greipp, P.R.; Solberg, L.A.; Witzig, T.E.; Garton, J.P.; Inwards, D.J. 1993: High-dose melphalan, cyclophosphamide, and total body irradiation followed by peripheral blood stem cell rescue in refractory and relapsing multiple myeloma. Clinical Research 41(3): 647A

Pineda-Roman, M.; Barlogie, B.; Anaissie, E.; Zangari, M.; Bolejack, V.; van Rhee, F.; Tricot, G.; Crowley, J. 2008: High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients. Cancer 112(8): 1754-1764

Burrows, K.B.; Meshul, C.K. 1997: High-dose methamphetamine alters GABA immunocytochemistry in caudate and globus pallidus. Society for Neuroscience Abstracts 23(1-2): 2144

Thomas, C.A.; Hesdorffer, C.S. 1998: High-dose methotrexate monotherapy in patients with CNS non-Hodgkins lymphoma. Blood 92(10 Suppl 1 Part 1-2): 240B

Hellier, I.; Bessis, D.; Sotto, A.; Margueritte, G.; Guilhou, J.J. 1996: High-dose methotrexate-induced bullous variant of acral erythema. Archives of Dermatology 132(5): 590-591

Hiçsönmez, G.; Cetin, M.; Tuneer, M.A.; Gümrük, F.; Ozbek, N.; Kara, A.; Gürgey, A. 1995: High-dose methylprednisolone for remission induction in hypoplastic acute myeloid leukemia. European Journal of Haematology 54(2): 125-126

Peces, R.; Urra, J.M.; Escalada, P.; Gorostidi, M.; González, E.; López-Larrea, C. 1993: High-dose methylprednisolone inhibits the OKT3-induced cytokine-related syndrome. Nephron 63(1): 118

Slivka, A.; Murphy, E.; Horrocks, L. 1993: High-dose methylprednisolone treatment in experimental focal stroke. Neurology 43(4 Suppl 2): A365-A366

Liu, G.T.; Glaser, J.S.; Schatz, N.J. 1993: High-dose methylprednisolone treatment of acute, severe visual loss in pseudotumor cerebri. Neurology 43(4 Suppl 2): A226

Sibal, A.; Davison, S.; Murphy, M.S. 1996: High-dose midazolam/meperidine sedation for pediatric endoscopy. Gastroenterology 110(4 Suppl): A39

Ayash, L.; Elias, A.; Cruz, J.; Lynch, J.; Wheeler, C.; Schwartz, G.; Tepler, I.; Schnipper, L.; Frei, E.; Weiner, R.; Hurd, D.; Antman, K. 1993: High-dose multimodality therapy for locally unresectable or inflammatory breast cancer. Breast Cancer Research and Treatment 27(1-2): 181

Kofke, W.A.; Garman, R.H.; Garman, R.; Rose, M. 1993: High-dose narcotics cause seizures and brain damage in ventilated rats. Anesthesiology 79(3A): A785

Kofke, W.A.; Garman, R.H.; Garman, R.; Rose, M. 1993: High-dose narcotics cause seizures and limbic brain damage in ventilated rats. Society for Neuroscience Abstracts 19(1-3): 1159

Velazquez Gonzalez, A.; Luis, A.; Hurtado, R.; Labardini, J.; Lopez, X. 1997: High-dose of etoposide-cyclophosphamide combination as intensive consolidation chemotherapy in adult acute lymphoblastic leukemia. Blood 90(10 Suppl 1 Pt 2): 248B

Schamassmann, A.; Peskar, B.M.; Varga, L.; Flogerzi, B.; Sanner, M.; Halter, F. 1993: High-dose omeprazole treatment largely reverses the deleterious effects of indomethacin on experimental gastric ulcer healing. Gastroenterology 104(4 Suppl): A186

Neri, M.; Susi, D.; Di Iorio, P.; Seccia, G.; Laterza, F.; Cuccurullo, F. 1994: High-dose omeprazole with clarithromycin for one week An effective dual therapy regimen for H pylori infection. Gastroenterology 106(4 Suppl): A148

Feld, R. 1994: High-dose or dose-intensive chemotherapy for non-small cell carcinoma of the lung. Seminars in Oncology 21(1 Suppl 1: 33-37

Vasquez, E.M.; Sanchez, J.; Pollak, R.; Vrahnos, D.; Fabrega, A.J.; Maddux, M.S. 1993: High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipients. Transplantation 55(2): 448-450

Malberti, F.; Scanziani, R.; Bellazzi, R.; Corradi, B.; Dozio, B.; Bonforte, G.; Imbasciati, E.; Surian, M. 1993: High-dose oral calcitriol and zero calcium solutions in CAPD patients with severe hyperparathyroidism. Nephrology Dialysis Transplantation 8(9): 1026

Beauduin, M.; Focan, C.; Majois, F.; Canon, J.P.; Cusumano, P.; Lobelle, J.P. 1998: High-dose oral medroxyprogesterone acetate versus tamoxifen for adjuvant hormonotherapy of node negative breast cancer An interim report on a randomised trial. Anticancer Research 18(6C): 4860-4861

Vermorken, J.B.; ten Bokkel Huinink, W.W.; Mandjes, I.A.; Postma, T.J.; Huizing, M.T.; Heimans, J.J.; Beijnen, J.H.; Bierhorst, F.; Winograd, B.; Pinedo, H.M. 1995: High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. Seminars in Oncology 22(4 Suppl 8: 16-22

Bleck, T.P. 1992: High-dose pentobarbital treatment of refractory status epilepticus A meta-analysis of published studies. Epilepsia 33(Suppl 3): 5

Chua, H.C.; Tan, A.K.Y.; Tan, C.B.; Tjia, H. 1997: High-dose phenobarbitone in status epilepticus. Journal of the Neurological Sciences 150(Suppl ): S163

Sweeten, B.J.; Shetty, A.K.; Aviles, D.H.; Irwin, K.C.; Dublin, L.; Vehaskari, V.M. 1998: High-dose pulse intravenous methylprednisolone therapy for steroid-resistant nephrotic syndrome in children. Journal of Investigative Medicine 46(1): 20A

Reboul, F.; Vincent, P.; Chauvet, B.; Plat, F.; Felix Faure, C.; Brewer, Y.; Taulelle, M. 1992: High-dose radiation therapy and concomitant continuous infusion cisplatin improve local control and possibly survival in unresectable non-small cell lung carcinoma. International Journal of Radiation Oncology Biology Physics 24(Suppl 1): 252

Toon, S.; Khan, A.; Holt, B.; Mullins, F.; Langley, S.; Rowland, M. 1993: High-dose ranitidine has no effect on alcohol pharmacokinetics. Gastroenterology 104(4 Suppl): A213

Adkins, D.; Spitzer, G.; Brown, R.; Goodnough, T.; Fadler, M.; Lin, H.; Di Persio, J. 1996: High-dose rate /low-dose single exposure total body irradiation as conditioning for allogeneic peripheral blood stem cell transplantation results in complete donor chimerism, and rapid engraftment without severe acute graft versus host disease or toxicity. Blood 88(10 Suppl 1 Part 1-2): 114A

Arterbery, V.E. 1993: High-dose rate brachytherapy for carcinoma of the cervix. Current Opinion in Oncology 5(6): 1005-1009

Reboul, F.; Chauvet, B.; Vincent, P.; Brewer, Y.; Felix Faure, C.; Taulelle, M. 1994: High-dose rate brachytherapy for endobronchial lung carcinoma Results and complications in 111 patients. European Journal of Cancer 30A(Suppl 1): S35

Sutedja, G.; Baris, G.; van Zandwijk, N.; Postmus, P.E. 1994: High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration; International Review of Thoracic Diseases 61(3): 167-168

Shirato, H.; Kagei, K.; Kitahara, H.M.D.; Tomita, M.; Takamura, A.; Arimoto, T.; Mizoe, J.; Matsuoka, S.; Suzuki, K.; Nishioka, T.; Fujimoto, S.; Miyasaka, K. 1996: High-dose rate intracavitary irradiation using linear source arrangement for squamous cell carcinoma of the uterine cervix. International Journal of Radiation Oncology Biology Physics 36(1 Suppl): 318

Chow, S.; Bosco, J.J.; Heiss, F.W.; Shea, J.A.; Healy, G.; Lo, T.; Molgard, C.; White, C. 1996: High-dose rate intraluminal brachytherapy and external beam radiation therapy for palliative treatment of malignant biliary obstruction. Gastroenterology 110(4 Suppl): A503

Kubota, Y.; Kin, H.; Takaoka, M.; Inoue, K.; Murata, T.; Tanaka, Y. 1996: High-dose rate intraluminal irradiation combined with biliary stenting for unresectable cholangiocarcinoma. Gastroenterology 110(4 Suppl): A464

Kubota, Y.; Takaoka, M.; Kin, H.; Ogura, M.; Yamamoto, S.; Tsuji, K.; Yanagitani, K.; Mizuno, T.; Inoue, K. 1997: High-dose rate intraluminal irradiation combined with endoscopic bilateral placements of Wallstents for hilar cholangiocarcinoma. Gastroenterology 112(4 Suppl): A512

Sachs, M.; Fong, K.L.; Blanchard, L.; Wikler, M. 1993: High-dose recombinant soluble CD4 in patients with HIV-1 infection. Abstracts of the General Meeting of the American Society for Microbiology 93: 437

Bongioanni, M.R.; Ferrero, B.; Geuna, M.; Ferri, R.; Aimo, G.; Durelli, L. 1994: High-dose recombinant-alpha-2a-interferon therapy modulates cytokine profile in MS. Journal of Neuroimmunology 54(1-2): 154

Schoenen, J.; Jacquy, J.; Lenaerts, M. 1997: High-dose riboflavin is effective in migraine prophylaxis Results from a double blind, randomized, placebo-controlled trial. Neurology 48(3 Suppl 2): A86-A87

Johnston, L.; Horning, S.; Stockerl Goldstein, K.; Hu, W.; Negrin, R.; Blume, K. 1998: High-dose sequential chemotherapy and purged autologous peripheral blood progenitor cell transplantation for refractory/recurrent non-Hodgkins lymphoma. Blood 92(10 Suppl 1 Part 1-2): 465A

Tarella, C.; Caracciolo, D.; Gavarotti, P.; Corradini, P.; Zallio, F.; Castellino, C.; Pileri, A. 1996: High-dose sequential chemotherapy as salvage treatment in 33 patients with refractory or relapsed non-Hodgkins lymphoma. Blood 88(10 Suppl 1 Part 1-2): 288B

Canales, M.; Ojeda, E.; Alvarez, M.T.; Jimenez, V.; Jimenez, M.T.; Hernandez, D.; Aguado, M.J.; Bustos, J.G.; Hernandez Navarro, F. 1998: High-dose sequential chemotherapy in the treatment of myeloma. British Journal of Haematology 102(1): 352

Patrone, F.; Ballestrero, A.; Brema, F.; Ferrando, F.; Ghio, R.; Gobbi, M.; Basta, P.; Stura, P. 1994: High-dose sequential chemotherapy with double haemopoietic progenitor cell rescue for poor risk breast cancer and NHL. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 134

Santini, G.; Congiu, A.M.; Nati, S.; Coser, P.; Leoni, P.; Sertoli, M.R.; Chisesi, T.; Salvagno, L.; Olivieri, A.; Porcellini, A.; Contu, A.; Brandes, A.; Spriano, M.; Pierluigi, D.; Biglio, A.; Damasio, E.; Rizzoli, V. 1996: High-dose sequential therapy for aggressive NHL with bone marrow involvement A report of the NHLCSG. British Journal of Haematology 93(Suppl 2): 89

Liblau, R.S.; Pearson, C.I.; Shokat, K.; Tisch, R.; Yang, X.D.; McDevitt, H.O. 1994: High-dose soluble antigen: peripheral T-cell proliferation or apoptosis. Immunological Reviews 142: 193-208

Zales, V.R.; Deal, B.J.; Pahl, E.; Wright, K.L.; Alboliras, E.T.; Crawford, S. 1994: High-dose steroid therapy for acute myocarditis in pediatric patients. Circulation 90(4 Part 2): I50

Bhargava, B.; Chopra, A.K.; Agarwal, R.; Narang, R.; Chopra, V.; Manchanda, S.C. 1998: High-dose streptokinase therapy for prosthetic valve thrombosis within 2 weeks of open heart surgery. International Journal of Cardiology 66(2): 143-145

Commissaris, R.L.; Hill, T.J. 1994: High-dose sub-acute imipramine treatment produces a delayed anticonflict in rats. Society for Neuroscience Abstracts 20(1-2): 384

Kamada, A.K.; Leung, D.Y.; Gleason, M.C.; Hill, M.R.; Szefler, S.J. 1992: High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response. Journal of Allergy and Clinical Immunology 90(4 Pt 1): 685-687

Hedlund, B.E.; Hallaway, P.E. 1993: High-dose systemic iron chelation attenuates reperfusion injury. Biochemical Society Transactions 21(2): 340-343

Perez, E.A.; Gandara, D.R.; Edelman, M.J.; Webber, L.W.; Degregorio, M.W. 1994: High-dose tamoxifen in combination with cisplatin Phase I trial and pharmacokinetic analysis. Proceedings of the American Association for Cancer Research Annual Meeting 35: 246

Mans, D.R.A.; Malcon, C.; Becker, D.; Grivicich, I.; LopesG.D., L.J.; Machado, V.L.; Scaletzky, A.; Pohlmann, P.R.; Jung, F.A.; Schwartsmann, G. 1995: High-dose tamoxifen interferes with etoposide disposition in the cerebrospinal fluid of glioma patients and P-glycoprotein-expressing tissues in rats. Proceedings of the American Association for Cancer Research Annual Meeting 36: 295

Anawalt, B.D.; Christensen, R.B.; Bebb, R.A.; Bremner, W.; Matsumoto, A.M. 1995: High-dose testosterone treatment in normal men Dose-dependent suppression of gonadotropins. Journal of Investigative Medicine 43(Suppl 1): 128A

Haas, R.; Hohaus, S.; Goldschmidt, H.; Möhle, R.; Witt, B.; Wannenmacher, M.; Hunstein, W. 1994: High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization. Seminars in Oncology 21(6 Suppl 16: 19-24

Fermand, J.P.; Ravaud, P.; Chevret, S.; Leblond, V.; Divine, M.; Dreyfus, F.; Belanger, C.; Troussard, X.; Mariette, X.; Brouet, J.C. 1995: High-dose therapy and autologous blood stem cell transplantation in multiple myeloma: preliminary results of a randomized trial involving 167 patients. Stem Cells 13(Suppl 2): 156-159

Nademanee, A.; Molina, A.; O'donnell, M.; Snyder, D.S.; Stein, A.; Parker, P.; Smith, E.; Kashyap, A.; Planas, I.; Spielberger, R.; Fung, H.; Somlo, G.; Margolin, K.; Chow, W.; Vora, N.; Dagis, A.; Niland, J.; Blume, K.G.; Forman, S.J. 1996: High-dose therapy and autologous bone marrow/stem cell transplantation as consolidation therapy during first CR/PR in patients with poor-risk intermediate-and high-grade lymphoma. Blood 88(10 Suppl 1 Part 1-2): 684A

Fermand, J.P.; Ravaud, P.; Chevret, S.; Divine, M.; Leblond, V.; Belanger, C.; Macro, M.; Pertuiset, E.; Dreyfus, F.; Mariette, X.; Boccacio, C.; Brouet, J.C. 1998: High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial. Blood 92(9): 3131-3136

Intragumtornchai, T.; Assawametha, N.; O'charoen, R.; Sutcharitchan, P.; Swasdikul, D. 1998: High-dose therapy and autologous peripheral blood stem cell transplantation is an effective therapy in patients with acute myelogenous leukemia in first remission. Blood 92(10 Suppl 1 Part 1-2): 366B

Nademanee, A.; Molina, A.; Smith, E.; Stein, A.; Planas, I.; Vora, N.; Forman, S.J. 1996: High-dose therapy and autologous peripheral blood stem transplantation during first remission in patients with advanced stages and poor-prognosis mantle cell lymphoma. Blood 88(10 Suppl 1 Part 1-2): 121A

Milone, G.; Koziner, B.; Milone, J.; Kusminsky, G.; Cerutti, I.; Bullorsky, E.; Milovic, V.; Basso, A.; Garcia, J. 1998: High-dose therapy and autologous progenitor cells transplantation in multiple myeloma reported from the GATMO. Blood 92(10 Suppl 1 Part 1-2): 369B

Nademanee, A.; Molina, A.; Palmer, J.; Rodriguez, R.; O'donnell, M.; Stein, A.; Snyder, D.S.; Parker, P.; Fung, H.C.; Kashyap, A.; Spielberger, R.; Krishnan, A.; Bhatia, R.; Hyde, S.; Niland, J.C.; Forman, S.J. 1998: High-dose therapy and autologous stem cell transplant for patients with primary mediastinal large cell lymphoma Analysis of prognostic factors. Blood 92(10 Suppl 1 Part 1-2): 462A

Nademanee, A.; Molina, A.; Stein, A.; Planas, I.; Fung, H.; Dagis, A.; O'donnell, M.R.; Snyder, D.S.; Parker, P.; Spielberger, R.; Kashyap, A.; Bhatia, R.; Krishnan, A.; Sniecinski, I.; Vora, N.; Forman, S.J. 1997: High-dose therapy and autologous stem cell transplantation as consolidation therapy during first complete remission or partial remission in patients with unfavorable prognosis and advanced stage Hodgkins disease. Blood 90(10 Suppl 1 Pt 1): 114A

Nademanee, A.; O'donnell, M.; Snyder, D.S.; Schmidt, G.M.; Parker, P.M.; Stein, A.S.; Smith, E.P.; Molina, A.; Stepan, D.E.; Wong, K.K.; Somlo, G.; Margolin, K.A.; Sniecinski, I.; Dagis, A.C.; Niland, J.; Pezner, R.; Forman, S.J. 1994: High-dose therapy and autologous stem cell transplantation for refractory Hodgkins disease Results and analysis of prognostic factors. Blood 84(10 Suppl 1): 206A

Moreau, P.; Facon, T.; Leblond, V.; Attal, M.; Caillot, D.; Nedellec, G.; Huynh, A.; Bataille, R.; Harousseau, J.L. 1997: High-dose therapy and autologous stem cell transplantation for systemic AL amyloidosis A report on 16 cases. Experimental Hematology 25(8): 787

Amoura, Z.; Leblond, V.; Azar, N.; Montalescot, G.; Bagnis, C.; Schmidt, J.; Gennes, C.D.; Wechsler, B.; Boccaccio, C.; Godeau, P.; Piette, J.C. 1998: High-dose therapy and autologous stem cell transplantation for systemic amyloidosis Report of 9 cases. Arthritis and Rheumatism 41(9 Suppl): S234

Carella, A. 1995: High-dose therapy and autologous stem cell transplantation in Hodgkins disease patients who progress after primary chemotherapy. Bone Marrow Transplantation 15(Suppl 1): S229

Faul, C.; Hebart, H.; Halene, S.; Jaschonek, K.; Brugger, W.; Einsele, H.; Kanz, L. 1996: High-dose therapy and autologous stem-cell transplantation for treatment of osteosclerotic myeloma. Annals of Hematology 73(Suppl 2): A111

Shahidi, H.; Gregory, S.A.; Gupta Burt, S.; Adler, S.S.; Venugopal, P.; Meyer, P.; Korenblit, A.D.; Recine, D.; Manson, S.; Kaizer, H. 1997: High-dose therapy and stem cell transplantation for relapsed or refractory non-Hodgkins lymphoma. Blood 90(10 Suppl 1 Pt 1): 232A-233A

Horning, S.J. 1997: High-dose therapy and transplantation for low-grade lymphoma. Hematology/Oncology Clinics of North America 11(5): 919-935

Zinzani, P.L.; Gherlinzoni, F.; Bendandi, M.; Tura, S. 1995: High-dose therapy followed by autologous bone marrow transplantation in previously untreated high grade non-Hodgkin's lymphoma: 10-year long-term results. European Journal of Cancer 31a (13-14): 2421-2422

Lerma, E.; Dejana, A.; Celesti, L.; Corsetti, M.T.; Bruni, R.; Frassoni, F.; Carella, A.M. 1998: High-dose therapy followed by autologous peripheral blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Experimental Hematology 26(8): 701

Elias, A.D. 1998: High-dose therapy for adult soft tissue sarcoma: dose response and survival. Seminars in Oncology 25(2 Suppl 4: 19-23; Discussion: 45-48

Santini, G.; Congiu, A.M.A.; Coser, P.; Sertoli, M.R.; Chisesi, T.; Salvagno, L.; Olivieri, A.; Porcelini, A.; Contu, A.; Nati, S.; Pierluigi, D.; Rizzoli, V. 1995: High-dose therapy for aggressive lymphomas with bone marrow involvement A report of the NHLCSG. Blood 86(10 Suppl 1): 964A

Vahdat, L.; Antman, K. 1995: High-dose therapy for breast cancer. Blood Reviews 9(3): 191-200

Shepherd, J.D.; Phillips, G.L. 1993: High-dose therapy for lymphoma. Current Opinion in Oncology 5(5): 797-804

Fields, K.K.; Perkins, J.B.; Partyka, J.S.; Elfenbein, G.J. 1996: High-dose therapy for the treatment of breast cancer: evaluation of effect of regimen on outcome. Bone Marrow Transplantation 18(Suppl 1): S30-S33

Attal, M.; Harousseau, J.L.; Stoppa, A.M.; Sotto, J.J.; Fuzibet, G.; Rossi, J.F.; Casassus, P.; Thyss, A.; Maisonneuve, H.; Facon, T.; Ifrah, N.; Payen, C.; Bataille, R. 1995: High-dose therapy in multiple myeloma A prospective randomized study of the Intergroupe Francais du Myelome. Stem Cells 13(Suppl 2): 147

Shpall, E.J.; Jones, R.B.; Bearman, S. 1994: High-dose therapy with autologous bone marrow transplantation for the treatment of solid tumors. Current Opinion in Oncology 6(2): 135-138

Zintl, F.; Schiller, I.; Suttorp, M.; Berthold, F.; Kabisch, H.; Peters, C.; Klingebiel, T.; Mueller Weihrich, S.; Bender Goetze, C.; Graf, N.; Friedrich, W.; Schellong, G.; Doerffel, W. 1998: High-dose therapy with autologous stem cell transplantation for recurrent or refractory Hodgkins disease in childhood. Blood 92(10 Suppl 1 Part 1-2): 374B

Socinski, M.A.; Shea, T.C. 1997: High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer. Seminars in Oncology 24(4 Suppl 12: S12

Fahlke, J.; Ridwelski, K.; Lippert, H. 1998: High-dose therapy with combined 5-FU and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma. Annals of Hematology 77(Suppl 2): S46

Haas, R.; Goldschmidt, H.; Moos, M.; Fruehauf, S.; Moehle, R.; Karcher, A.; Witt, B.; Flentje, M.; Wannemacher, M.; Hunstein, W. 1995: High-dose therapy with peripheral blood stem cell support in patients with non-Hodgkins lymphoma. Zeller, W J , Eisenbrand, G , Hellmann, K Contributions to Oncology; Reduction of anticancer drug toxicity: Pharmacologic, biologic, immunologic and gene therapeutic approaches 72-79

Haas, R.; Murea, S.; Moos, M.; Hohaus, S.; Goldschmidt, H.; Hunstein, W. 1996: High-dose therapy with peripheral blood stem cell transplantation in low-grade non-Hodgkins Lymphomas. Blood 88(10 Suppl 1 Part 1-2): 120A

Mureau, S.; Moos, M.; Voso, M.T.; Hohaus, S.; Goldschmidt, H.; Wannenmacher, M.; Haas, R. 1997: High-dose therapy with peripheral blood stem cell transplantation in patients with indolent non-Hodgkins lymphomas. Experimental Hematology 25(8): 848

Buske, C.; Hiddemann, W. 1998: High-dose therapy with peripheral blood stem cell transplantation in patients with low-grade non-Hodgkins lymphoma. Annals of Hematology 77(Suppl 2): S26

Martin, S.; Moos, M.; Voso, M.T.; Hohaus, S.; Ho, A.D.; Haas, R. 1998: High-dose therapy with peripheral blood stem cell transplantation in patients with low-grade non-Hodgkins lymphomas. Blood 92(10 Suppl 1 Part 1-2): 460A